@prefix : <http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure> .
@prefix dc: <http://purl.org/dc/elements/1.1/> .
@prefix mp: <http://purl.org/mp/> .
@prefix oa: <http://www.w3.org/ns/oa#> .
@prefix obo: <http://purl.obolibrary.org/obo/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xml: <http://www.w3.org/XML/1998/namespace> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix core: <http://purl.obolibrary.org/obo/uberon/core#> .
@prefix foaf: <http://xmlns.com/foaf/0.1/> .
@prefix pato: <http://purl.obolibrary.org/obo/pato#> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix time: <http://www.w3.org/2006/time#> .
@prefix core1: <http://purl.obolibrary.org/obo/core#> .
@prefix terms: <http://purl.org/dc/terms/> .
@prefix uberon: <http://purl.obolibrary.org/obo/uberon#> .
@prefix subsets: <http://purl.obolibrary.org/obo/ro/subsets#> .
@prefix oboInOwl: <http://www.geneontology.org/formats/oboInOwl#> .
@prefix OpenPVSignal: <http://purl.org/OpenPVSignal/OpenPVSignal.owl#> .
@base <http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure> .

<http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure> rdf:type owl:Ontology ;
                                                                         owl:imports <http://purl.org/OpenPVSignal/OpenPVSignal.owl> ,
                                                                                     mp: ;
                                                                         rdfs:isDefinedBy "https://apps.who.int/iris/handle/10665/255514/"^^xsd:anyURI ;
                                                                         rdfs:label "Vemurafenib and renal failure"^^xsd:Literal ;
                                                                         owl:versionInfo "draft-v0.95-20211112"@en .

#################################################################
#    Object Properties
#################################################################

###  http://purl.org/OpenPVSignal/OpenPVSignal.owl#Free_text_reporting_element
OpenPVSignal:Free_text_reporting_element rdf:type owl:ObjectProperty .


###  http://purl.org/mp/references
mp:references rdf:type owl:ObjectProperty .


#################################################################
#    Data properties
#################################################################

###  http://purl.org/mp/citation
mp:citation rdf:type owl:DatatypeProperty .


#################################################################
#    Individuals
#################################################################

###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#BRAF_V600_mutation_positive
:BRAF_V600_mutation_positive rdf:type owl:NamedIndividual ,
                                      OpenPVSignal:Indication ;
                             OpenPVSignal:has_MedDRA_code 10075676 ;
                             OpenPVSignal:has_MedDRA_prefered_term "BRAF V600E mutation positive" ;
                             rdfs:label "BRAF V600 mutation positive" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#DiscussionAndConclusion
:DiscussionAndConclusion rdf:type owl:NamedIndividual ,
                                  OpenPVSignal:Conclusion ,
                                  OpenPVSignal:Discussion ;
                         mp:references :Ref.5 ;
                         OpenPVSignal:has_content """Case reports in VigiBase suggest that there is a signal for the association of vemurafenib and renal failure.
There are 23 reports of ARF, 14 reports of CRF and one report of renal failure aggravated with both ARF and CRF described in one report. There are some issues in terminology with the reports of CRF. In MedDRA, there are separate preferred terms (PTs) for ARF, CRF and renal failure  (RF). In WHO-ART, however, RF  is an included term with CRF in the PTCRF. This means that reports of CRF may be renal failure without further qualification. Vemurafenib was the only drug suspected in all 38 cases except three. In these three cases, there was one other suspected drug: ibuprofen, iodine and piperacillin/tazobactam.
Time to onset was reported in 14 of the reports and ranged from two days to six months. The six reports with a time to onset within a month are suggestive of a drug-induced effect. The outcome was stated in 21 reports. The patients were reported as recovered or recovering in 12 cases, not recovered in six cases and the outcome was fatal in two reports. The cases of recovery or recovering on drug withdrawal and the case of recurrence of renal failure on rechallenge are highly suggestive of a drug-induced effect.
Concomitant drugs were reported in 23 cases and included drugs used in a patient population which might be at risk of renal failure due to the presence of hypertension, diabetes and infection. There were also a number of concomitant reactions that may have caused or made a contribution to the cause of the renal failure. It is also possible that the underlying disease may have been responsible in some cases.
There are no reports in the literature of renal failure in association with vemurafenib. There is, however, an isolated report of renal failure in a patient taking vemurafenib, and a recent review of the on-target toxicities of TKIs noted that renal failure is an effect of  the TKIs bosutinib, dasatinib, erlotinib, imatinib, nilotinib, sorafenib and sunitinib.5 In conclusion, although renal failure may have other possible causes in this series of patients, the use of  vemurafenib appears the most likely reason.
""" ;
                         rdfs:label "Discussion and conclusion" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Dr_Ian_Boyd
:Dr_Ian_Boyd rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Author ;
             OpenPVSignal:has_first_name "Ian" ;
             OpenPVSignal:has_last_name "Boyd" ;
             rdfs:label "Dr Ian Boyd" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Fatal_case_of_renal_failure_in_patient_with_vemurafenib
:Fatal_case_of_renal_failure_in_patient_with_vemurafenib rdf:type owl:NamedIndividual ,
                                                                  obo:OAE_0001197 ,
                                                                  OpenPVSignal:Clinical_trial_information ;
                                                         OpenPVSignal:refers_to_adverse_effect :renalFailureAcute ;
                                                         OpenPVSignal:refers_to_drug :vemurafenib ;
                                                         mp:references :Ref.4 ;
                                                         OpenPVSignal:has_content "There is, however, an isolated report of renal failure in a patient taking vemurafenib. In a Phase II trial of the efficacy of the drug in 132 patients, one patient died owing to rapid progression of melanoma and ARF, possibly related to the study drug.4" ;
                                                         rdfs:label "Fatal case of renal failure in patient with vemurafenib" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#IC025_for_vemurafenib_and_ARF
:IC025_for_vemurafenib_and_ARF rdf:type owl:NamedIndividual ,
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Information_Component__025_(IC025)> ;
                               OpenPVSignal:refers_to_adverse_effect :renalFailureAcute ;
                               OpenPVSignal:refers_to_drug :vemurafenib ;
                               OpenPVSignal:refers_to_information_component :IC_for_vemurafenib_and_ARF ;
                               OpenPVSignal:has_value 0.66 ;
                               rdfs:label "IC025 for vemurafenib and ARF" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#IC025_for_vemurafenib_and_CRF
:IC025_for_vemurafenib_and_CRF rdf:type owl:NamedIndividual ,
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Information_Component__025_(IC025)> ;
                               OpenPVSignal:refers_to_adverse_effect :renalFailureChronic ;
                               OpenPVSignal:refers_to_drug :vemurafenib ;
                               OpenPVSignal:refers_to_information_component :IC_for_vemurafenib_and_CRF ;
                               OpenPVSignal:has_value 0.28 ;
                               rdfs:label "IC025 for vemurafenib and CRF" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#IC025_for_vemurafenib_and_renal_failure_aggravated
:IC025_for_vemurafenib_and_renal_failure_aggravated rdf:type owl:NamedIndividual ,
                                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Information_Component__025_(IC025)> ;
                                                    OpenPVSignal:refers_to_adverse_effect :renalFailureAggravated ;
                                                    OpenPVSignal:refers_to_drug :vemurafenib ;
                                                    OpenPVSignal:refers_to_information_component :IC_for_vemurafenib_and_renal_failure_aggravated ;
                                                    OpenPVSignal:has_value -2.97 ;
                                                    rdfs:label "IC025 for vemurafenib and renal failure aggravated" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#IC_for_vemurafenib_and_ARF
:IC_for_vemurafenib_and_ARF rdf:type owl:NamedIndividual ,
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Information_Component_(IC)> ;
                            OpenPVSignal:refers_to_adverse_effect :renalFailureAcute ;
                            OpenPVSignal:refers_to_drug :vemurafenib ;
                            OpenPVSignal:has_value 1.30 ;
                            rdfs:label "IC for vemurafenib and ARF" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#IC_for_vemurafenib_and_CRF
:IC_for_vemurafenib_and_CRF rdf:type owl:NamedIndividual ,
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Information_Component_(IC)> ;
                            OpenPVSignal:refers_to_adverse_effect :renalFailureChronic ;
                            OpenPVSignal:refers_to_drug :vemurafenib ;
                            OpenPVSignal:has_value 1.08 ;
                            rdfs:label "IC for vemurafenib and CRF" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#IC_for_vemurafenib_and_renal_failure_aggravated
:IC_for_vemurafenib_and_renal_failure_aggravated rdf:type owl:NamedIndividual ,
                                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Information_Component_(IC)> ;
                                                 OpenPVSignal:refers_to_adverse_effect :renalFailureAggravated ;
                                                 OpenPVSignal:refers_to_drug :vemurafenib ;
                                                 OpenPVSignal:has_value 0.83 ;
                                                 rdfs:label "IC for vemurafenib and renal failure aggravated" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#IntroductionContent
:IntroductionContent rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Introduction ;
                     mp:references :Ref.1 ,
                                   :Ref.2 ,
                                   :Ref.3 ;
                     OpenPVSignal:has_content """Vemurafenib is a low molecular weight, orally available, inhibitor of BRAF serine-threonine kinase (a member of the Raf kinase family of growth signal transduction protein kinases). Mutations in the BRAF gene which substitute the valine at amino acid position 600 result in constitutively activated BRAF proteins, which can cause cell proliferation in the absence of growth factors that would normally be required for proliferation.1 Before taking vemurafenib, patients must have BRAF V600 mutation-positive tumour status confirmed by a validated test. It is one of the medications widely known as tyrosine kinase inhibitors (TKIs) but should be referred to as protein kinase inhibitors because although the earliest drugs in this class were TKIs, they can now be further categorized based upon the amino acid that they phosphorylate:  serine,  threonine or tyrosine. Vemurafenib is indicated in monotherapy for the treatment of adult patients with BRAF V600 mutation-positive unresectable or metastatic melanoma. The most common adverse drug reactions (ADR) reported with vemurafenib (>30%) reported with vemurafenib include arthralgia, fatigue, rash, photosensitivity reaction, nausea, alopecia and pruritus. Cutaneous squamous cell carcinoma (CuSCC) was very commonly reported and was most commonly treated by local excision. There are warnings in the product information concerning the possible occurrence of severe hypersensitivity and dermatological reactions, QT prolongation, serious ophthalmologic reactions, new primary melanomas, liver laboratory abnormalities and mild to severe photosensitivity.1
Renal failure is a reduction or suppression of the excretory function of the kidney, characterized by a decrease in creatinine clearance.2  Renal failure is demonstrated by an increase in serum creatinine above 150 mmol/L, or reduction in creatinine clearance below 50 mL/ min per 1.73 m2 of body surface. Age, sex, weight and whether the patient is pregnant should be considered in determining abnormality of levels of serum creatinine or creatinine clearance. The presenting symptoms of drug-induced renal failure are the same as those for renal failure due to other causes. Drugs can cause renal failure, which may be acute (developing within hours or days), subacute (within weeks), or chronic (within months or years); they may also exacerbate pre- existing renal failure. Whenever possible in reporting a suspected adverse drug reaction, the pre-existing level of renal function should be included in addition to the actual change in function.2
The cause of acute renal failure (ARF) can be characterised based on where the injury has occurred.3 Pre-renal causes include hypovolaemia, dehydration due to vomiting, diarrhoea, sweating or fever, poor intake of  fluids, medications such as diureticâ€™s and abnormal blood flow due to obstruction. Renal causes include sepsis, medications such as NSAIDs, antibiotics such as aminoglycosides, lithium and iodine, rhabdomyolysis, multiple myeloma and glomerulonephritis. Post-renal causes include obstruction of the bladder or the ureters, prostatic hypertrophy or prostate cancer, abdominal tumours or kidney stones. The most common causes of chronic renal failure (CRF) are poorly controlled diabetes, poorly controlled hypertension and chronic glomerulonephritis. Other causes 
include polycystic kidney disease, reflux nephropathy, kidney stones and prostate disease.3""" ;
                     rdfs:label "Introduction content" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Literature_and_Labelling
:Literature_and_Labelling rdf:type owl:NamedIndividual ,
                                   OpenPVSignal:Literature_information ;
                          mp:references :Ref.1 ,
                                        :Ref.4 ,
                                        :Ref.5 ;
                          OpenPVSignal:has_content "The product literature does not refer to renal failure or any other renal reaction1. There is a warning in the product information regarding renal impairment which indicates that no adjustment to the starting dose is needed for patients with mild or moderate renal impairment. There are only limited data available in patients with severe renal impairment. Vemurafenib should be used with caution in patients with severe renal impairment and patients should be closely monitored1. There are no reports in the literature of renal failure in association with vemurafenib. There is, however, an isolated report of renal failure in a patient taking vemurafenib. In a Phase II trial of the efficacy of the drug in 132 patients, one patient died owing to rapid  progression of  melanoma and ARF, possibly related to the study drug.4 A recent review of the on-target toxicities of TKIs noted that renal failure is an effect of the TKIs bosutinib, dasatinib, erlotinib, imatinib, nilotinib, sorafenib and sunitinib.5" ;
                          rdfs:label "Literature and Labelling" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#MechanismContent
:MechanismContent rdf:type owl:NamedIndividual ,
                           OpenPVSignal:Mechanism ;
                  mp:references :Ref.1 ;
                  OpenPVSignal:has_content "Vemurafenib is a low molecular weight, orally available, inhibitor of BRAF serine-threonine kinase (a member of the Raf kinase family of growth signal transduction protein kinases). Mutations in the BRAF gene which substitute the valine at amino acid position 600 result in constitutively activated BRAF proteins, which can cause cell proliferation in the absence of growth factors that would normally be required for proliferation.1 Before taking vemurafenib, patients must have BRAF V600 mutation-positive tumour status confirmed by a validated test. It is one of the medications widely known as tyrosine kinase inhibitors (TKIs) but should be referred to as protein kinase inhibitors because although the earliest drugs in this class were TKIs, they can now be further categorized based upon the amino acid that they phosphorylate:  serine,  threonine or tyrosine." ;
                  rdfs:label "Mechanism content" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#MetastaticMalignantMelanoma
:MetastaticMalignantMelanoma rdf:type owl:NamedIndividual ,
                                      OpenPVSignal:Indication ;
                             OpenPVSignal:has_ICD_code "C43.9" ;
                             OpenPVSignal:has_MedDRA_code 10027480 ;
                             OpenPVSignal:has_MedDRA_prefered_term "Metastatic malignant melanoma" ;
                             rdfs:label "Metastatic malignant melanoma" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Patient1
:Patient1 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_gender "male" ;
          rdfs:label "Patient 1" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Patient10
:Patient10 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 52 ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 10" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Patient11
:Patient11 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 62 ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 11" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Patient12
:Patient12 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 54 ;
           OpenPVSignal:has_gender "female" ;
           rdfs:label "Patient 12" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Patient13
:Patient13 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 64 ;
           OpenPVSignal:has_gender "female" ;
           rdfs:label "Patient 13" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Patient14
:Patient14 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 57 ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 14" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Patient15
:Patient15 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 63 ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 15" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Patient16
:Patient16 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 64 ;
           OpenPVSignal:has_gender "female" ;
           rdfs:label "Patient 16" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Patient17
:Patient17 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 62 ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 17" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Patient18
:Patient18 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 73 ;
           OpenPVSignal:has_gender "female" ;
           rdfs:label "Patient 18" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Patient19
:Patient19 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 73 ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 19" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Patient2
:Patient2 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_age 66 ;
          OpenPVSignal:has_gender "male" ;
          rdfs:label "Patient 2" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Patient20
:Patient20 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 70 ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 20" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Patient21
:Patient21 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 75 ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 21" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Patient22
:Patient22 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           rdfs:label "Patient 22" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Patient23
:Patient23 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 23" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Patient24
:Patient24 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 24" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Patient25
:Patient25 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 66 ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 25" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Patient26
:Patient26 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_gender "female" ;
           rdfs:label "Patient 26" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Patient27
:Patient27 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 27" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Patient28
:Patient28 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_gender "female" ;
           rdfs:label "Patient 28" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Patient29
:Patient29 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 29" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Patient3
:Patient3 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_gender "female" ;
          rdfs:label "Patient 3" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Patient30
:Patient30 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           rdfs:label "Patient 30" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Patient31
:Patient31 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 38 ;
           OpenPVSignal:has_gender "female" ;
           rdfs:label "Patient 31" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Patient32
:Patient32 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 56 ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 32" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Patient33
:Patient33 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_gender "female" ;
           rdfs:label "Patient 33" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Patient34
:Patient34 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 44 ;
           OpenPVSignal:has_gender "female" ;
           rdfs:label "Patient 34" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Patient35
:Patient35 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 57 ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 35" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Patient36
:Patient36 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 44 ;
           OpenPVSignal:has_gender "female" ;
           rdfs:label "Patient 36" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Patient37
:Patient37 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 89 ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 37" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Patient38
:Patient38 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 75 ;
           OpenPVSignal:has_gender "male" ;
           rdfs:label "Patient 38" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Patient39
:Patient39 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 74 ;
           OpenPVSignal:has_gender "female" ;
           rdfs:label "Patient 39" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Patient4
:Patient4 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_gender "female" ;
          rdfs:label "Patient 4" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Patient40
:Patient40 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           rdfs:label "Patient 40" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Patient41
:Patient41 rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Patient ;
           OpenPVSignal:has_age 81 ;
           rdfs:label "Patient 41" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Patient5
:Patient5 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_gender "female" ;
          rdfs:label "Patient 5" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Patient6
:Patient6 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_age 63 ;
          OpenPVSignal:has_gender "male" ;
          rdfs:label "Patient 6" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Patient7
:Patient7 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_age 61 ;
          OpenPVSignal:has_gender "male" ;
          rdfs:label "Patient 7" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Patient8
:Patient8 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_gender "female" ;
          rdfs:label "Patient 8" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Patient9
:Patient9 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Patient ;
          OpenPVSignal:has_age 72 ;
          OpenPVSignal:has_gender "male" ;
          rdfs:label "Patient 9" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Ref.1
:Ref.1 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "European Medicines Agency Summary of Product Characteristics for vemurafenib (Zelboraf). URL: http://www.ema.europa.eu/ docs/en_GB/document_library/ EPAR_-_Product_Information/human/002409/ WC500124317.pdf. Accessed: 30 October 2013." ;
       rdfs:label "Ref.1" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Ref.2
:Ref.2 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "The Council for International Organizations of Medical Sciences (CIOMS). Reporting Adverse Drug Reactions: Definitions of Terms and Criteria for their Use. CIOMS, Geneva, 1999. URL: http://www.cioms.ch/publications/ reporting_adverse_drug.pdf. Accessed: 30 October 2013." ;
       rdfs:label "Ref.2" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Ref.3
:Ref.3 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "Wedro B, author, Stoppler MC, editor. Kidney failure. Medicine.net.com. URL: http://www.medicinenet.com/kidney_failure/page2.htm. Accessed: 5 November 2013." ;
       rdfs:label "Ref.3" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Ref.4
:Ref.4 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "Sosman JA, Kim KB, Schuchter L, Gonzalez R, Pavlick AC, Weber JS et al. Survival in BRAF V600- mutant advance melanoma treated with vemurafenib. N Engl J Med. 2012;366:707-14." ;
       rdfs:label "Ref.4" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Ref.5
:Ref.5 rdf:type owl:NamedIndividual ,
                OpenPVSignal:Bibliographic_reference ;
       OpenPVSignal:has_content "Shah DR, Shah RR, Morganroth J. Tyrosine kinase inhibitors: their on-target toxicities as potential indicators of toxicity. Drug Saf. 2013;36:413-26." ;
       rdfs:label "Ref.5" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Renal_toxicity_of_TKIs
:Renal_toxicity_of_TKIs rdf:type owl:NamedIndividual ,
                                 obo:OAE_0001197 ;
                        OpenPVSignal:refers_to_adverse_effect :renalFailure ;
                        OpenPVSignal:refers_to_drug :bosutinib ,
                                                    :dasatinib ,
                                                    :erlotinib ,
                                                    :imatinib ,
                                                    :nilotinib ,
                                                    :sorafenib ,
                                                    :sunitinib ;
                        mp:references :Ref.5 ;
                        OpenPVSignal:has_content "A recent review of the on-target toxicities of TKIs noted that renal failure is an effect of the TKIs bosutinib, dasatinib, erlotinib, imatinib, nilotinib, sorafenib and sunitinib.5" ;
                        rdfs:label "Renal toxicity of TKIs" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Report1
:Report1 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:refers_to_adverse_effect :arthralgia ,
                                               :liverFunctionAbnormal ,
                                               :renalFailureAcute ,
                                               :renalFunctionAbnormal ;
         OpenPVSignal:refers_to_patient :Patient1 ;
         OpenPVSignal:refers_to_primary_suspect_drug :vemurafenib ;
         OpenPVSignal:refers_to_secondary_suspect_drug :ibuprofen ;
         OpenPVSignal:refers_to_outcome_after_action "unknown" ;
         rdfs:label "Report 1" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Report10
:Report10 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :renalFailureAcute ;
          OpenPVSignal:refers_to_concomitant_drug :olmesartan ;
          OpenPVSignal:refers_to_patient :Patient10 ;
          OpenPVSignal:refers_to_primary_suspect_drug :vemurafenib ;
          OpenPVSignal:refers_to_outcome_after_action "recovery with no further information" ;
          rdfs:label "Report 10" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Report11
:Report11 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :infection ,
                                                :renalFailureAcute ;
          OpenPVSignal:refers_to_concomitant_drug :ciprofloxacin ,
                                                  :methylprednisolone ;
          OpenPVSignal:refers_to_patient :Patient11 ;
          OpenPVSignal:refers_to_primary_suspect_drug :vemurafenib ;
          OpenPVSignal:refers_to_outcome_after_action "no recovery" ;
          rdfs:label "Report 11" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Report12
:Report12 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :angioedema ,
                                                :arthralgia ,
                                                :drugEruption ,
                                                :rashmaculo-papular ,
                                                :renalFailureAcute ;
          OpenPVSignal:refers_to_patient :Patient12 ;
          OpenPVSignal:refers_to_primary_suspect_drug :vemurafenib ;
          OpenPVSignal:refers_to_outcome_after_action "unknown" ;
          rdfs:label "Report 12" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Report13
:Report13 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :appetiteDecreased ,
                                                :chestDiscomfort ,
                                                :hypovolaemia ,
                                                :rash ,
                                                :rashErythematous ,
                                                :renalFailureAcute ,
                                                :systemicInflammatoryResponseSyndrome ;
          OpenPVSignal:refers_to_patient :Patient13 ;
          OpenPVSignal:refers_to_primary_suspect_drug :vemurafenib ;
          OpenPVSignal:refers_to_outcome_after_action "recovery with no further information" ;
          rdfs:label "Report 13" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Report14
:Report14 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :dehydration ,
                                                :renalFailureAcute ;
          OpenPVSignal:refers_to_concomitant_drug :omeprazole ,
                                                  :perindopril ,
                                                  :propranolol ,
                                                  :sertraline ,
                                                  :vardenafil ;
          OpenPVSignal:refers_to_patient :Patient14 ;
          OpenPVSignal:refers_to_primary_suspect_drug :vemurafenib ;
          OpenPVSignal:refers_to_outcome_after_action "unknown" ;
          rdfs:label "Report 14" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Report15
:Report15 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :hypokinesia ,
                                                :renalFailureAcute ,
                                                :ventricularDysfunction ;
          OpenPVSignal:refers_to_concomitant_drug :iodine ,
                                                  :lactulose ,
                                                  :lansoprazole ,
                                                  :levothyroxine ,
                                                  :metformin ,
                                                  :oxycodone ,
                                                  :rosuvastatin ,
                                                  :simvastatin ,
                                                  :tamsulosin ;
          OpenPVSignal:refers_to_patient :Patient15 ;
          OpenPVSignal:refers_to_primary_suspect_drug :vemurafenib ;
          OpenPVSignal:refers_to_outcome_after_action "recovery with no further information" ;
          rdfs:label "Report 15" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Report16
:Report16 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :chestDiscomfort ,
                                                :hypophagia ,
                                                :hypovolaemia ,
                                                :rashErythematous ,
                                                :renalFailure ,
                                                :renalFailureAcute ,
                                                :systemicInflammatoryResponseSyndrome ;
          OpenPVSignal:refers_to_patient :Patient16 ;
          OpenPVSignal:refers_to_primary_suspect_drug :vemurafenib ;
          OpenPVSignal:refers_to_outcome_after_action "recovery with no further information" ;
          rdfs:label "Report 16" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Report17
:Report17 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :infection ,
                                                :renalFailureAcute ;
          OpenPVSignal:refers_to_concomitant_drug :ciprofloxacin ,
                                                  :methylprednisolone ;
          OpenPVSignal:refers_to_patient :Patient17 ;
          OpenPVSignal:refers_to_primary_suspect_drug :vemurafenib ;
          OpenPVSignal:refers_to_outcome_after_action "no recovery" ;
          rdfs:label "Report 17" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Report18
:Report18 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :renalFailureAcute ;
          OpenPVSignal:refers_to_concomitant_drug :meropenem ;
          OpenPVSignal:refers_to_patient :Patient18 ;
          OpenPVSignal:refers_to_primary_suspect_drug :vemurafenib ;
          OpenPVSignal:refers_to_outcome_after_action "recovery with no further information" ;
          rdfs:label "Report 18" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Report19
:Report19 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :cardiacFailure ,
                                                :lungOedema ,
                                                :renalFailureAcute ;
          OpenPVSignal:refers_to_patient :Patient19 ;
          OpenPVSignal:refers_to_primary_suspect_drug :vemurafenib ;
          OpenPVSignal:refers_to_outcome_after_action "recovery with no further information" ;
          rdfs:label "Report 19" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Report2
:Report2 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:refers_to_adverse_effect :anorexia ,
                                               :diarrhoea ,
                                               :fever ,
                                               :renalFailureAcute ,
                                               :tremor ;
         OpenPVSignal:refers_to_concomitant_drug :paracetamol ,
                                                 :tamsulosin ;
         OpenPVSignal:refers_to_patient :Patient2 ;
         OpenPVSignal:refers_to_primary_suspect_drug :vemurafenib ;
         OpenPVSignal:refers_to_outcome_after_action "recovery with no further information" ;
         rdfs:label "Report 2" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Report20
:Report20 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :alopecia ,
                                                :appetiteDecreased ,
                                                :asthenia ,
                                                :constipation ,
                                                :creatinineClearanceDecreased ,
                                                :hyperkalaemia ,
                                                :nausea ,
                                                :rash ,
                                                :renalFailureAcute ,
                                                :sunburn ,
                                                :urinaryTractInfection ,
                                                :vomiting ,
                                                :weightDecrease ;
          OpenPVSignal:refers_to_concomitant_drug :acarbose ,
                                                  :atorvastatin ,
                                                  :dimenhydrinate ,
                                                  :diphenhydramine ,
                                                  :ergocalciferol ,
                                                  :hydrocortisone ,
                                                  :irbesartan ,
                                                  :iron ,
                                                  :magnesiumOxide ,
                                                  :metformin ,
                                                  :metoclopramide ,
                                                  :pantoprazole ,
                                                  :pioglitazone ,
                                                  :sennaGlycosides ,
                                                  :sodiumPolystyreneSulfonate ,
                                                  <http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#menthol/zincOxide> ;
          OpenPVSignal:refers_to_patient :Patient20 ;
          OpenPVSignal:refers_to_primary_suspect_drug :vemurafenib ;
          OpenPVSignal:refers_to_outcome_after_action "unknown" ;
          rdfs:label "Report 20" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Report21
:Report21 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :diarrhoea ,
                                                :renalFailureAcute ,
                                                :sloughingOfSkin ;
          OpenPVSignal:refers_to_patient :Patient21 ;
          OpenPVSignal:refers_to_primary_suspect_drug :vemurafenib ;
          OpenPVSignal:refers_to_outcome_after_action "unknown" ;
          rdfs:label "Report 21" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Report22
:Report22 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :dehydration ,
                                                :hypotension ,
                                                :rash ,
                                                :renalFailureAcute ;
          OpenPVSignal:refers_to_patient :Patient22 ;
          OpenPVSignal:refers_to_primary_suspect_drug :vemurafenib ;
          OpenPVSignal:refers_to_outcome_after_action "recovering" ;
          rdfs:label "Report 22" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Report23
:Report23 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :congestiveHeartFailure ,
                                                :pneumonia ,
                                                :renalFailureAcute ;
          OpenPVSignal:refers_to_concomitant_drug :milrinone ;
          OpenPVSignal:refers_to_patient :Patient23 ;
          OpenPVSignal:refers_to_primary_suspect_drug :vemurafenib ;
          OpenPVSignal:refers_to_outcome_after_action "unknown" ;
          rdfs:label "Report 23" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Report24
:Report24 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :cholecystitis ,
                                                :pancreatitis ,
                                                :renalFailureAcute ;
          OpenPVSignal:refers_to_concomitant_drug :candesartan ,
                                                  :fentanyl ,
                                                  :finasteride ,
                                                  :metamizole ,
                                                  :timolol ,
                                                  <http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#sodiumbicarbonate/potassium> ;
          OpenPVSignal:refers_to_patient :Patient24 ;
          OpenPVSignal:refers_to_primary_suspect_drug :vemurafenib ;
          OpenPVSignal:refers_to_outcome_after_action "unknown" ;
          rdfs:label "Report 24" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Report25
:Report25 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :congestiveHeartFailure ,
                                                :pneumonia ,
                                                :renalFailureAcute ;
          OpenPVSignal:refers_to_concomitant_drug :atorvastatin ,
                                                  :carvedilol ,
                                                  :furosemide ,
                                                  :lisinopril ,
                                                  :paroxetine ,
                                                  :spironolactone ;
          OpenPVSignal:refers_to_patient :Patient25 ;
          OpenPVSignal:refers_to_primary_suspect_drug :vemurafenib ;
          OpenPVSignal:refers_to_outcome_after_action "recovery with no further information" ;
          rdfs:label "Report 25" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Report26
:Report26 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :cardiacArrestIncident ,
                                                :renalFailureAcute ,
                                                :respiratoryArrest ;
          OpenPVSignal:refers_to_concomitant_drug :allopurinol ,
                                                  :antibiotics ,
                                                  :anticoagulants ,
                                                  :antidiabetics ,
                                                  :antihypertensives ,
                                                  :hypolipidaemics ,
                                                  :protonPumpInhibitors ;
          OpenPVSignal:refers_to_patient :Patient26 ;
          OpenPVSignal:refers_to_primary_suspect_drug :vemurafenib ;
          OpenPVSignal:refers_to_secondary_suspect_drug <http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#piperacillin/tazobactam> ;
          OpenPVSignal:refers_to_outcome_after_action "irrelevant death" ;
          rdfs:label "Report 26" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Report27
:Report27 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :lymphoedema ,
                                                :renalFailure ;
          OpenPVSignal:refers_to_patient :Patient27 ;
          OpenPVSignal:refers_to_primary_suspect_drug :vemurafenib ;
          OpenPVSignal:refers_to_outcome_after_action "unknown" ;
          rdfs:label "Report 27" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Report28
:Report28 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :fatigue ,
                                                :rash ,
                                                :renalFailure ;
          OpenPVSignal:refers_to_patient :Patient28 ;
          OpenPVSignal:refers_to_primary_suspect_drug :vemurafenib ;
          OpenPVSignal:refers_to_outcome_after_action "recovering" ;
          rdfs:label "Report 28" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Report29
:Report29 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :creatineBloodIncreased ,
                                                :renalFailure ;
          OpenPVSignal:refers_to_patient :Patient29 ;
          OpenPVSignal:refers_to_primary_suspect_drug :vemurafenib ;
          OpenPVSignal:refers_to_outcome_after_action "unknown" ;
          rdfs:label "Report 29" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Report3
:Report3 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:refers_to_adverse_effect :dehydration ,
                                               :hypotensive ,
                                               :nausea ,
                                               :renalFailureAcute ,
                                               :vomiting ;
         OpenPVSignal:refers_to_concomitant_drug :calciumCarbonate ,
                                                 :lisinopril ,
                                                 :ondansetron ,
                                                 :promethazine ,
                                                 <http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#chlortalidone/atenolol> ,
                                                 <http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#paracetamol_/_hydrocodone> ,
                                                 <http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#vitamins/minerals> ;
         OpenPVSignal:refers_to_patient :Patient3 ;
         OpenPVSignal:refers_to_primary_suspect_drug :vemurafenib ;
         OpenPVSignal:refers_to_outcome_after_action "recovery with no further information" ;
         rdfs:label "Report 3" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Report30
:Report30 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :alkalinePhosphataseSerumIncreased ,
                                                :arthralgia ,
                                                :asthenia ,
                                                :cholestasisIntrahepatic ,
                                                :erythema ,
                                                :keratocanthoma ,
                                                :keratosis ,
                                                :photosensitivityReaction ,
                                                :rashmaculo-papular ,
                                                :renalFailure ;
          OpenPVSignal:refers_to_patient :Patient30 ;
          OpenPVSignal:refers_to_primary_suspect_drug :vemurafenib ;
          OpenPVSignal:refers_to_outcome_after_action "unknown" ;
          rdfs:label "Report 30" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Report31
:Report31 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :legPain ,
                                                :myalgia ,
                                                :renalFailure ;
          OpenPVSignal:refers_to_concomitant_drug :enoxaparin ,
                                                  :prednisolone ,
                                                  :pregabalin ,
                                                  :ranitidine ,
                                                  :tamsulosin ,
                                                  <http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#sodiumbicarbonate/potassiumchloride/sodiumchloride/macrogol> ;
          OpenPVSignal:refers_to_patient :Patient31 ;
          OpenPVSignal:refers_to_primary_suspect_drug :vemurafenib ;
          OpenPVSignal:refers_to_outcome_after_action "no recovery" ;
          rdfs:label "Report 31" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Report32
:Report32 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :blisters ,
                                                :bloodSugarIncreased ,
                                                :bonePain ,
                                                :headache ,
                                                :hypotension ,
                                                :itching ,
                                                :jointPain ,
                                                :muscleAche ,
                                                :nausea ,
                                                :paraesthesia ,
                                                :rash ,
                                                :renalFailure ,
                                                :sunburn ,
                                                :uricAcidBloodIncreased ;
          OpenPVSignal:refers_to_concomitant_drug :allopurinol ,
                                                  :celecoxib ,
                                                  :naproxen ,
                                                  :paracetamol ;
          OpenPVSignal:refers_to_patient :Patient32 ;
          OpenPVSignal:refers_to_primary_suspect_drug :vemurafenib ;
          OpenPVSignal:refers_to_outcome_after_action "unknown" ;
          rdfs:label "Report 32" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Report33
:Report33 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :arthralgia ,
                                                :diarrhoea ,
                                                :pancreatitis ,
                                                :pyrexia ,
                                                :rash ,
                                                :renalFailure ;
          OpenPVSignal:refers_to_concomitant_drug :clonidine ,
                                                  :docusate ,
                                                  :glipizide ,
                                                  :hydrochlorothiazide ,
                                                  :metformin ,
                                                  :metoprolol ,
                                                  :omeprazole ,
                                                  :potassium ,
                                                  :valaciclovir ,
                                                  <http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#valsartan/amlodipine> ;
          OpenPVSignal:refers_to_patient :Patient33 ;
          OpenPVSignal:refers_to_primary_suspect_drug :vemurafenib ;
          OpenPVSignal:refers_to_outcome_after_action "unknown" ;
          rdfs:label "Report 33" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Report34
:Report34 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :renalFailure ;
          OpenPVSignal:refers_to_concomitant_drug :colecalciferol ,
                                                  :dexamethasone ,
                                                  :hydrochlorothiazide ,
                                                  :metformin ,
                                                  :pantoprazole ,
                                                  :ramipril ,
                                                  :sitagliptin ,
                                                  :valproicAcid ,
                                                  <http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#citricacid/potassiumbicarbonate/PotassiumCitrate> ;
          OpenPVSignal:refers_to_patient :Patient34 ;
          OpenPVSignal:refers_to_primary_suspect_drug :vemurafenib ;
          OpenPVSignal:refers_to_outcome_after_action "no recovery" ;
          rdfs:label "Report 34" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Report35
:Report35 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :hepaticFailure ,
                                                :renalFailure ,
                                                :sepsis ;
          OpenPVSignal:refers_to_concomitant_drug :imipenem ,
                                                  :pantoprazole ,
                                                  :ramipril ,
                                                  <http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#amoxicillin_sodium/_clavulanate_potassium> ;
          OpenPVSignal:refers_to_patient :Patient35 ;
          OpenPVSignal:refers_to_primary_suspect_drug :vemurafenib ;
          OpenPVSignal:refers_to_outcome_after_action "death" ;
          rdfs:label "Report 35" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Report36
:Report36 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :renalFailure ;
          OpenPVSignal:refers_to_concomitant_drug :dexamethasone ,
                                                  :ergocalciferol ,
                                                  :hydrochlorothiazide ,
                                                  :metformin ,
                                                  :pantoprazole ,
                                                  :potassium ,
                                                  :ramipril ,
                                                  :sitagliptin ,
                                                  :valproicAcid ;
          OpenPVSignal:refers_to_patient :Patient36 ;
          OpenPVSignal:refers_to_primary_suspect_drug :vemurafenib ;
          OpenPVSignal:refers_to_outcome_after_action "no recovery" ;
          rdfs:label "Report 36" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Report37
:Report37 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :renalFailure ,
                                                :sepsis ;
          OpenPVSignal:refers_to_patient :Patient37 ;
          OpenPVSignal:refers_to_primary_suspect_drug :vemurafenib ;
          OpenPVSignal:refers_to_outcome_after_action "death" ;
          rdfs:label "Report 37" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Report38
:Report38 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :diarrhoea ,
                                                :nausea ,
                                                :rash ,
                                                :renalFailureChronic ;
          OpenPVSignal:refers_to_concomitant_drug :acetylsalicylicAcid ,
                                                  :allopurinol ,
                                                  :codeine ,
                                                  :codeineAndParacetamol ,
                                                  :furosemide ,
                                                  :irbesartan ,
                                                  :lisinopril ,
                                                  :metoprolol ,
                                                  :prazosin ,
                                                  :simvastatin ;
          OpenPVSignal:refers_to_patient :Patient38 ;
          OpenPVSignal:refers_to_primary_suspect_drug :vemurafenib ;
          OpenPVSignal:refers_to_outcome_after_action "unknown" ;
          rdfs:label "Report 38" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Report39
:Report39 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :hepaticFunctionAbnormal ,
                                                :hyponatraemia ,
                                                :laboratoryTestFalse ,
                                                :qtProlonged ,
                                                :renalFailure ;
          OpenPVSignal:refers_to_concomitant_drug :hydrochlorothiazide ,
                                                  :lovastatin ,
                                                  :nadolol ;
          OpenPVSignal:refers_to_patient :Patient39 ;
          OpenPVSignal:refers_to_primary_suspect_drug :vemurafenib ;
          OpenPVSignal:refers_to_outcome_after_action "recovery with no further information" ;
          rdfs:label "Report 39" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Report4
:Report4 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:refers_to_adverse_effect :diarrhoea ,
                                               :nausea ,
                                               :renalFailureAcute ,
                                               :vomiting ;
         OpenPVSignal:refers_to_patient :Patient4 ;
         OpenPVSignal:refers_to_primary_suspect_drug :vemurafenib ;
         OpenPVSignal:refers_to_outcome_after_action "unknown" ;
         rdfs:label "Report 4" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Report40
:Report40 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :renalFailure ;
          OpenPVSignal:refers_to_patient :Patient40 ;
          OpenPVSignal:refers_to_primary_suspect_drug :vemurafenib ;
          OpenPVSignal:refers_to_outcome_after_action "unknown" ;
          rdfs:label "Report 40" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Report41
:Report41 rdf:type owl:NamedIndividual ,
                   OpenPVSignal:VigiBase_Report ;
          OpenPVSignal:refers_to_adverse_effect :liverFunctionTestsAbnormalNos ,
                                                :rash ,
                                                :renalFailureAggravated ;
          OpenPVSignal:refers_to_concomitant_drug :acetylsalicylicAcid ,
                                                  :amlodipine ,
                                                  :metoprolol ,
                                                  :molsidomine ,
                                                  :pantoprazole ;
          OpenPVSignal:refers_to_patient :Patient41 ;
          OpenPVSignal:refers_to_primary_suspect_drug :vemurafenib ;
          OpenPVSignal:refers_to_outcome_after_action "unknown" ;
          rdfs:label "Report 41" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Report5
:Report5 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:refers_to_adverse_effect :cardiacFailure ,
                                               :renalFailureAcute ;
         OpenPVSignal:refers_to_patient :Patient5 ;
         OpenPVSignal:refers_to_primary_suspect_drug :vemurafenib ;
         OpenPVSignal:refers_to_outcome_after_action "unknown" ;
         rdfs:label "Report 5" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Report6
:Report6 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:refers_to_adverse_effect :renalFailureAcute ;
         OpenPVSignal:refers_to_concomitant_drug :allopurinol ,
                                                 :nifedipine ,
                                                 :oxycodone ,
                                                 :paracetamol ,
                                                 :simvastatin ,
                                                 :temazepam ,
                                                 <http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#sodiumbicarbonate/potassiumchloride/sodiumchloride/macrogol> ;
         OpenPVSignal:refers_to_patient :Patient6 ;
         OpenPVSignal:refers_to_primary_suspect_drug :vemurafenib ;
         OpenPVSignal:refers_to_outcome_after_action "no recovery" ;
         rdfs:label "Report 6" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Report7
:Report7 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:refers_to_adverse_effect :cardiacFailure ,
                                               :creatinineClearanceDecreased ,
                                               :oedema ,
                                               :pleuralEffusion ,
                                               :renalFailureAcute ,
                                               :renalFunctionAbnormal ,
                                               :respiratoryArrest ,
                                               :ureaBloodIncreased ;
         OpenPVSignal:refers_to_concomitant_drug :codeineAndParacetamol ,
                                                 :dexamethasone ,
                                                 :spironolactone ,
                                                 :zopiclone ;
         OpenPVSignal:refers_to_patient :Patient7 ;
         OpenPVSignal:refers_to_primary_suspect_drug :vemurafenib ;
         OpenPVSignal:refers_to_outcome_after_action "no recovery" ;
         rdfs:label "Report 7" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Report8
:Report8 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:refers_to_adverse_effect :dehydration ,
                                               :diarrhoea ,
                                               :metastasesNos ,
                                               :rash ,
                                               :renalFailureAcute ;
         OpenPVSignal:refers_to_concomitant_drug :aprepitant ,
                                                 :dexamethasone ,
                                                 :escitalopram ,
                                                 :nystatin ,
                                                 :ondansetron ,
                                                 :oxycodone ,
                                                 :phytomenadione ,
                                                 :potassium ,
                                                 :temozolomide ,
                                                 :warfarin ,
                                                 :zopiclone ;
         OpenPVSignal:refers_to_patient :Patient8 ;
         OpenPVSignal:refers_to_primary_suspect_drug :vemurafenib ;
         OpenPVSignal:refers_to_outcome_after_action "recovery with no further information" ;
         rdfs:label "Report 8" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Report9
:Report9 rdf:type owl:NamedIndividual ,
                  OpenPVSignal:VigiBase_Report ;
         OpenPVSignal:refers_to_adverse_effect :renalFailureAcute ;
         OpenPVSignal:refers_to_concomitant_drug :allopurinol ,
                                                 :felodopine ,
                                                 :metolazone ,
                                                 :metoprolol ,
                                                 :propylene_glycol ;
         OpenPVSignal:refers_to_patient :Patient9 ;
         OpenPVSignal:refers_to_primary_suspect_drug :vemurafenib ;
         OpenPVSignal:refers_to_outcome_after_action "no recovery" ;
         rdfs:label "Report 9" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#ReportsFromAustralia
:ReportsFromAustralia rdf:type owl:NamedIndividual ,
                               OpenPVSignal:Reports_group ;
                      OpenPVSignal:is_subgroup_of :reportsAfterEliminationOfDuplicates ;
                      OpenPVSignal:has_count 3 ;
                      OpenPVSignal:refers_to_country "http://dbpedia.org/resource/Australia" ;
                      OpenPVSignal:refers_to_database "WHO Vigibase" ;
                      rdfs:label "Reports from Australia" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#ReportsFromAustria
:ReportsFromAustria rdf:type owl:NamedIndividual ,
                             OpenPVSignal:Reports_group ;
                    OpenPVSignal:is_subgroup_of :reportsAfterEliminationOfDuplicates ;
                    OpenPVSignal:has_count 2 ;
                    OpenPVSignal:refers_to_country "http://dbpedia.org/resource/Austria" ;
                    OpenPVSignal:refers_to_database "WHO Vigibase" ;
                    rdfs:label "Reports from Austria" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#ReportsFromBelgium
:ReportsFromBelgium rdf:type owl:NamedIndividual ,
                             OpenPVSignal:Reports_group ;
                    OpenPVSignal:is_subgroup_of :reportsAfterEliminationOfDuplicates ;
                    OpenPVSignal:has_count 1 ;
                    OpenPVSignal:refers_to_country "http://dbpedia.org/resource/Belgium" ;
                    OpenPVSignal:refers_to_database "WHO Vigibase" ;
                    rdfs:label "Reports from Belgium" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#ReportsFromCanada
:ReportsFromCanada rdf:type owl:NamedIndividual ,
                            OpenPVSignal:Reports_group ;
                   OpenPVSignal:is_subgroup_of :reportsAfterEliminationOfDuplicates ;
                   OpenPVSignal:has_count 2 ;
                   OpenPVSignal:refers_to_country "http://dbpedia.org/resource/Canada" ;
                   OpenPVSignal:refers_to_database "WHO Vigibase" ;
                   rdfs:label "Reports from Canada" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#ReportsFromGermany
:ReportsFromGermany rdf:type owl:NamedIndividual ,
                             OpenPVSignal:Reports_group ;
                    OpenPVSignal:is_subgroup_of :reportsAfterEliminationOfDuplicates ;
                    OpenPVSignal:has_count 4 ;
                    OpenPVSignal:refers_to_country "http://dbpedia.org/resource/Germany" ;
                    OpenPVSignal:refers_to_database "WHO Vigibase" ;
                    rdfs:label "Reports from Germany" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#ReportsFromGreece
:ReportsFromGreece rdf:type owl:NamedIndividual ,
                            OpenPVSignal:Reports_group ;
                   OpenPVSignal:is_subgroup_of :reportsAfterEliminationOfDuplicates ;
                   OpenPVSignal:has_count 1 ;
                   OpenPVSignal:refers_to_country "http://dbpedia.org/resource/Greece" ;
                   OpenPVSignal:refers_to_database "WHO Vigibase" ;
                   rdfs:label "Reports from Greece" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#ReportsFromItaly
:ReportsFromItaly rdf:type owl:NamedIndividual ,
                           OpenPVSignal:Reports_group ;
                  OpenPVSignal:is_subgroup_of :reportsAfterEliminationOfDuplicates ;
                  OpenPVSignal:has_count 1 ;
                  OpenPVSignal:refers_to_country "http://dbpedia.org/resource/Italy" ;
                  OpenPVSignal:refers_to_database "WHO Vigibase" ;
                  rdfs:label "Reports from Italy" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#ReportsFromNetherladnds
:ReportsFromNetherladnds rdf:type owl:NamedIndividual ,
                                  OpenPVSignal:Reports_group ;
                         OpenPVSignal:is_subgroup_of :reportsAfterEliminationOfDuplicates ;
                         OpenPVSignal:has_count 1 ;
                         OpenPVSignal:refers_to_country "http://dbpedia.org/resource/Netherlands" ;
                         OpenPVSignal:refers_to_database "WHO Vigibase" ;
                         rdfs:label "Reports from Netherladnds" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#ReportsFromSweden
:ReportsFromSweden rdf:type owl:NamedIndividual ,
                            OpenPVSignal:Reports_group ;
                   OpenPVSignal:is_subgroup_of :reportsAfterEliminationOfDuplicates ;
                   OpenPVSignal:has_count 1 ;
                   OpenPVSignal:refers_to_country "http://dbpedia.org/resource/Sweden" ;
                   OpenPVSignal:refers_to_database "WHO Vigibase" ;
                   rdfs:label "Reports from Sweden" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#ReportsFromSwitzerland
:ReportsFromSwitzerland rdf:type owl:NamedIndividual ,
                                 OpenPVSignal:Reports_group ;
                        OpenPVSignal:is_subgroup_of :reportsAfterEliminationOfDuplicates ;
                        OpenPVSignal:has_count 1 ;
                        OpenPVSignal:refers_to_country "http://dbpedia.org/resource/Switzerland" ;
                        OpenPVSignal:refers_to_database "WHO Vigibase" ;
                        rdfs:label "Reports from Switzerland" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#ReportsFromUnitedKingdom
:ReportsFromUnitedKingdom rdf:type owl:NamedIndividual ,
                                   OpenPVSignal:Reports_group ;
                          OpenPVSignal:is_subgroup_of :reportsAfterEliminationOfDuplicates ;
                          OpenPVSignal:has_count 1 ;
                          OpenPVSignal:refers_to_country "http://dbpedia.org/resource/United_Kingdom" ;
                          OpenPVSignal:refers_to_database "WHO Vigibase" ;
                          rdfs:label "Reports from United Kingdom" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#ReportsFromUnitedStates
:ReportsFromUnitedStates rdf:type owl:NamedIndividual ,
                                  OpenPVSignal:Reports_group ;
                         OpenPVSignal:is_subgroup_of :reportsAfterEliminationOfDuplicates ;
                         OpenPVSignal:has_count 20 ;
                         OpenPVSignal:refers_to_country "http://dbpedia.org/resource/United_States" ;
                         OpenPVSignal:refers_to_database "WHO Vigibase" ;
                         rdfs:label "Reports from United States" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#ReportsInVigibase
:ReportsInVigibase rdf:type owl:NamedIndividual ,
                            OpenPVSignal:Free_text_reporting_element ;
                   OpenPVSignal:has_content """As of 3 September 2013  there  were  25 Individual Case Safety  Reports  (ICSRs)  of  ARF in association with vemurafenib in the WHO Global
ICSR Database, VigiBaseTM. The association has an IC value of 1.30 with an IC025 value of 0.66. In addition there are 16 ICSRs of CRF in association with vemurafenib.  The association has an IC value of 1.08 with an IC025 value of
0.28. There is also one ICSR of renal failure aggravated (IC 0.83, IC025 -2.97).
The cases can be analysed together. There are pairs of duplicates in the ARF and in the CRF series (Table 1). After elimination of duplicates, there are 38 cases. The cases were submitted from the United States (20 cases), Germany (four), Australia (three), Canada and Austria (two cases each), Belgium, Greece, Italy, the Netherlands, Sweden, Switzerland and the United Kingdom (all one each). The patients ranged in age from 38 to 89 years. The gender distribution was 22 males, 13 females and 3 not specified.
Vemurafenib was the only drug suspected in all 38 cases except three. In these three cases, there was one other suspected drug: ibuprofen, iodine and piperacillin/ tazobactam. Concomitant drugs were reported in 24 cases and included antihypertensive drugs (14 cases), proton pump inhibitors (nine), pain management drugs (10), hypolipidaemics (seven), and drugs for the treatment of diabetes, constipation and infection (five each). There was also use of allopurinol and corticosteroids (five cases each).
Time to onset was reported in 14 of the 38  ICSRs. It ranged from three days to six months. The outcome was stated in 21 reports. The patients were reported as recovered or recovering in 12 cases, not recovered in seven cases and the outcome was fatal in the remaining two reports. The reason for death in one case was renal failure, hepatic failure and sepsis while in the other case, renal failure was stated to be contributory to the death. In another case in which the patient had not recovered from renal failure, the patient died, with the cause of death given as respiratory arrest. In the ICSRs were the outcome was reported as recovered or recovering, there was a positive dechallenge in three cases. In one of these cases, there was a negative rechallenge in that the reaction did not recur when the drug was re-introduced. In five other cases, a positive dechallenge could not be confirmed to a lack of detail but appeared likely and in another three cases, recovery followed  withdrawal but onset was also after drug withdrawal. In the cases where the patients had not recovered, the drug was withdrawn in three cases, continued in one case and the dose was reduced in one case. In the remaining two cases, the patient recovered with drug withdrawal but the reaction recurred on rechallenge and the patient had not recovered from that episode.
Other reactions were described in 31 of the reports. These reactions included skin reactions, abnormal liver function, nausea, diarrhoea, joint problems, dehydration and cardiac failure, vomiting and infection. Many of these reactions may have caused or made a contribution to the cause of the ARF.""" ;
                   rdfs:label "Reports in vigibase" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Response_from_Roche
:Response_from_Roche rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Response_to_Pharmacovigilance_Signal_Report ;
                     OpenPVSignal:refers_to_pharmacovigilance_signal_report :Vemurafenib_and_renal_failure ;
                     OpenPVSignal:has_content """Response from Roche
Thank you for the opportunity to provide our comments on your article, acute renal failure with vemurafenib.
Roche already completed an assessment of this adverse event on 15 October 2013. This signal was detected internally during the companyâ€™s review of Serious Unlisted Related (SUR) listings last July. In the SUR listing review, the number of renal events was raised as a concern as well as a literature abstract1 that reported the deterioration of renal function in a group of patients receiving vemurafenib. In September of this year, the Pharmacovigilance Risk Assessment Committee (PRAC) also requested Roche to review cases of acute renal failure and to look into the role of dehydration to identify plausible mechanisms, groups at risk, and the role of other factors in the occurrence of this event.
A cumulative review of vemurafenib cases entered in the Roche global drug safety database until 25 June 2013 was undertaken using the broad MedDRA SMQ for acute renal failure (ARF) which includes preferred terms of renal failure, renal impairment, clinical manifestations of oedema, decreased urine output, and abnormal laboratory findings of creatinine and blood urea among others. Data from preclinical studies, clinical trials, epidemiologic studies and the published literature were also reviewed.
There were 156 cases retrieved from the search of which 93 case reports were confirmed to include significant acute kidney injury (AKI) or acute renal failure. In 8 of the 93 cases, ARF was caused secondary to drug reaction with eosinophilia and systemic symptoms (DRESS), which is a labelled event. The majority, 49 out of the 93 cases, presented with alternative risk factors other than vemurafenib treatment: 19 cases (20.4 %) occurred in association with adverse events of nausea, vomiting, diarrhoea or dehydration and in three cases (3.2%) due to aggravation of pre-existing dehydration. The remaining 36 cases presented with insufficient information.
Using a recent population-based study2 which estimated the incidence of acute renal failure per the RIFLE classification including all severity levels of risk: injury, failure, loss of kidney function, end-stage renal disease among patients with cancer by type, we compared the number of cases retrieved from our search .In that study, the incidence of all severity grades of RIFLE combined was 4.5% among melanoma patients with a baseline creatinine measurement and  1.6% among melanoma patients without a baseline creatinine measurement. Based on an
 


estimated cumulative exposure of 19,926 vemurafenib patients and the 156 cases identified from the broad SMQ of Acute Renal Failure (includes terms of non-confirmed events of ARF such as increased creatinine), a conservative reporting rate of AKI/ARF for vemurafenib is 0.8% (156/19,926), lower than the rate of ARF for metastatic melanoma patients cited in the above literature (1.6% - 4.5%).
In addition, laboratory results from the pivotal randomized phase III trial, NO25026 (BRIM3) showed that there is no difference between arms (vemurafenib versus dacarbazine) in higher grades (3 + 4) of creatinine increase. This finding supports that vemurafenib is not directly nephrotoxic.
After this review of the available clinical data, a direct nephrotoxic effect of vemurafenib cannot be established. Although cases of dehydration (caused by nausea, vomiting, or diarrhoea, which are labelled events for vemurafenib) were identified to precede the AKI/ARF, the small number of these cases seen during this assessment within the context of the terminally ill patient population, a causal relationship cannot be established. Roche concluded that vemurafenib is not causally associated with ARF. Roche continues to closely monitor the events of AKI/ARF and related event of dehydration.
Reference:
1.	Uthurriague C et al. Degradation of renal function with vemurafenib treatment: an unknown but common adverse event. Annales de Dermatologie et de Venerologie 2012 Nov 25:B97-B97.
2.	Christiansen CF, Johansen MB, Langeberg WJ, Fryzek JP, Sorensen HT. Incidence of acute  kidney injury in cancer patients: a Danish population-based cohort study. Eur J Int Med 2011; 22(4): 399-406.""" ;
                     rdfs:label "Response from Roche" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#SummaryContent
:SummaryContent rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Summary ;
                OpenPVSignal:has_content "Vemurafenib is a low molecular weight, orally available, inhibitor of BRAF serine-threonine kinase (a member of the Raf kinase family of growth signal transduction protein kinases). It is one of the medications widely known as tyrosine kinase inhibitors (TKIs) but should be referred to as protein kinase inhibitors (PKIs). Vemurafenib is indicated in monotherapy for the treatment of adult patients with BRAF V600 mutation- positive unresectable or metastatic melanoma. In the WHO Global Individual Case Safety Report (ICSR) Database, VigiBaseTM there are currently (3 September 2013) 25 ICSRs of renal failure acute (ARF) in association with vemurafenib. In addition, there are 16 ICSRs of renal failure chronic (CRF) in association with vemurafenib, both combinations with a positive IC value. There is also one ICSR of renal failure aggravated. After elimination of duplicates, there are 38 ICSRs of renal failure. Vemurafenib was the only drug suspected in all but three cases. Time to onset was reported in 14 cases and ranged from three days to six months. The six reports with a time to onset within a month are suggestive of a drug-induced effect. Patients were reported as recovered or recovering in 12 cases, not recovered in seven cases and the outcome was fatal in two ICSRs. The cases reported as recovered or recovering together with the two cases of rechallenge are highly suggestive of a drug-induced effect. In conclusion, although renal failure may have other possible causes in this series of patients, the use of vemurafenib appears the most likely reason." ;
                rdfs:label "Summary content" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#Vemurafenib_and_renal_failure
:Vemurafenib_and_renal_failure rdf:type owl:NamedIndividual ,
                                        OpenPVSignal:Pharmacovigilance_Signal_Report ;
                               OpenPVSignal:refers_to_author :Dr_Ian_Boyd ;
                               OpenPVSignal:refers_to_signal :pvSignal ;
                               OpenPVSignal:has_creation_date "01/07/2014" ;
                               OpenPVSignal:has_overall_conclusion "causal association most probable" ;
                               rdfs:label "Vemurafenib and renal failure" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#acarbose
:acarbose rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Drug ;
          OpenPVSignal:has_ATC_code "A10BD17" ,
                                    "A10BF01" ;
          rdfs:label "acarbose" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#acetylsalicylicAcid
:acetylsalicylicAcid rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Drug ;
                     OpenPVSignal:has_ATC_code "A01AD05" ,
                                               "B01AC06" ,
                                               "B01AC56" ,
                                               "C10BX01" ,
                                               "C10BX02" ,
                                               "C10BX04" ,
                                               "C10BX05" ,
                                               "C10BX06" ,
                                               "C10BX08" ,
                                               "M01BA03" ,
                                               "N02BA01" ,
                                               "N02BA51" ,
                                               "N02BA71" ;
                     rdfs:label "acetylsalicylic acid" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#alkalinePhosphataseSerumIncreased
:alkalinePhosphataseSerumIncreased rdf:type owl:NamedIndividual ,
                                            OpenPVSignal:Adverse_Effect ;
                                   OpenPVSignal:has_ICD_code "R748" ;
                                   OpenPVSignal:has_MedDRA_code 10059570 ;
                                   OpenPVSignal:has_MedDRA_prefered_term "Blood alkaline phosphatase increased" ;
                                   rdfs:label "alkaline phosphatase serum increased" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#allopurinol
:allopurinol rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "M04AA01" ,
                                       "M04AA51" ;
             rdfs:label "allopurinol" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#alopecia
:alopecia rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Adverse_Effect ;
          OpenPVSignal:has_ICD_code "L659" ;
          OpenPVSignal:has_MedDRA_code 10001760 ;
          OpenPVSignal:has_MedDRA_prefered_term "Alopecia" ;
          rdfs:label "alopecia" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#amlodipine
:amlodipine rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "C08CA01" ,
                                      "C08GA02" ,
                                      "C09BB03" ,
                                      "C09BB04" ,
                                      "C09BB07" ,
                                      "C09BX01" ,
                                      "C09DB01" ,
                                      "C09DB02" ,
                                      "C09DB04" ,
                                      "C09DB05" ,
                                      "C09DB06" ,
                                      "C09DB07" ,
                                      "C09DX01" ,
                                      "C09DX03" ,
                                      "C09XA53" ,
                                      "C09XA54" ,
                                      "C10BX03" ,
                                      "C10BX07" ,
                                      "C10BX09" ,
                                      "C10BX11" ;
            rdfs:label "amlodipine" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#angioedema
:angioedema rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Adverse_Effect ;
            OpenPVSignal:has_ICD_code "T783XXA" ;
            OpenPVSignal:has_MedDRA_code 10002424 ;
            OpenPVSignal:has_MedDRA_prefered_term "Angioedema" ;
            rdfs:label "angioedema" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#anorexia
:anorexia rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Adverse_Effect ;
          OpenPVSignal:has_ICD_code "R630" ;
          OpenPVSignal:has_MedDRA_code 10061428 ;
          OpenPVSignal:has_MedDRA_prefered_term "Decreased appetite" ;
          rdfs:label "anorexia" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#antibiotics
:antibiotics rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "A07AA" ,
                                       "C05AB" ,
                                       "D01AA" ,
                                       "G01AA" ,
                                       "J02AA" ,
                                       "J04AB" ,
                                       "R02AB" ,
                                       "S01AA" ;
             rdfs:label "antibiotics" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#anticoagulants
:anticoagulants rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Drug ;
                OpenPVSignal:has_ATC_code "B01" ;
                rdfs:label "anticoagulants" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#antidiabetics
:antidiabetics rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Drug ;
               OpenPVSignal:has_ATC_code "A10" ;
               rdfs:label "antidiabetics" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#antihypertensives
:antihypertensives rdf:type owl:NamedIndividual ,
                            OpenPVSignal:Drug ;
                   OpenPVSignal:has_ATC_code "C02" ;
                   rdfs:label "antihypertensives" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#appetiteDecreased
:appetiteDecreased rdf:type owl:NamedIndividual ,
                            OpenPVSignal:Adverse_Effect ;
                   OpenPVSignal:has_ICD_code "R630" ;
                   OpenPVSignal:has_MedDRA_code 10061428 ;
                   OpenPVSignal:has_MedDRA_prefered_term "Decreased appetite" ;
                   rdfs:label "appetite decreased" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#aprepitant
:aprepitant rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "A04AD12" ;
            rdfs:label "aprepitant" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#arthralgia
:arthralgia rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Adverse_Effect ;
            OpenPVSignal:has_ICD_code "M2550" ;
            OpenPVSignal:has_MedDRA_code 10003239 ;
            OpenPVSignal:has_MedDRA_prefered_term "Arthralgia" ;
            rdfs:label "arthralgia" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#asthenia
:asthenia rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Adverse_Effect ;
          OpenPVSignal:has_ICD_code "R53" ;
          OpenPVSignal:has_MedDRA_code 10003549 ;
          OpenPVSignal:has_MedDRA_prefered_term "Asthenia" ;
          rdfs:label "asthenia" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#atorvastatin
:atorvastatin rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Drug ;
              OpenPVSignal:has_ATC_code "C10AA05" ,
                                        "C10BA05" ,
                                        "C10BX03" ,
                                        "C10BX06" ,
                                        "C10BX08" ,
                                        "C10BX11" ;
              rdfs:label "atorvastatin" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#blisters
:blisters rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Adverse_Effect ;
          OpenPVSignal:has_ICD_code "S90821A" ;
          OpenPVSignal:has_MedDRA_code 10005191 ;
          OpenPVSignal:has_MedDRA_prefered_term "Blister" ;
          rdfs:label "blisters" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#bloodSugarIncreased
:bloodSugarIncreased rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Adverse_Effect ;
                     OpenPVSignal:has_ICD_code "R73" ;
                     OpenPVSignal:has_MedDRA_code 10005557 ;
                     OpenPVSignal:has_MedDRA_prefered_term "Blood glucose increased" ;
                     rdfs:label "blood sugar increased" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#bonePain
:bonePain rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Adverse_Effect ;
          OpenPVSignal:has_ICD_code "G4763" ;
          OpenPVSignal:has_MedDRA_code 10006002 ;
          OpenPVSignal:has_MedDRA_prefered_term "Bone pain" ;
          rdfs:label "bone pain" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#bosutinib
:bosutinib rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "L01EA04" ;
           rdfs:label "bosutinib" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#calciumCarbonate
:calciumCarbonate rdf:type owl:NamedIndividual ,
                           OpenPVSignal:Drug ;
                  OpenPVSignal:has_ATC_code "A02AC01" ,
                                            "A11GB01" ,
                                            "A12AA04" ;
                  rdfs:label "calcium carbonate" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#candesartan
:candesartan rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "C09CA06" ,
                                       "C09DA06" ,
                                       "C09DB07" ;
             rdfs:label "candesartan" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#cardiacArrestIncident
:cardiacArrestIncident rdf:type owl:NamedIndividual ,
                                OpenPVSignal:Adverse_Effect ;
                       OpenPVSignal:has_ICD_code "I46.9" ;
                       OpenPVSignal:has_MedDRA_code 10007515 ;
                       OpenPVSignal:has_MedDRA_prefered_term "Cardiac arrest" ;
                       rdfs:label "cardiac arrest incident" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#cardiacFailure
:cardiacFailure rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Adverse_Effect ;
                OpenPVSignal:has_ICD_code "I50" ;
                OpenPVSignal:has_MedDRA_code 10007554 ;
                OpenPVSignal:has_MedDRA_prefered_term "Cardiac failure" ;
                rdfs:label "cardiac failure" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#carvedilol
:carvedilol rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "C07AG02" ;
            rdfs:label "carvedilol" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#celecoxib
:celecoxib rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "G01AE10" ,
                                     "L01XX33" ,
                                     "M01AH01" ;
           rdfs:label "celecoxib" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#chestDiscomfort
:chestDiscomfort rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Adverse_Effect ;
                 OpenPVSignal:has_ICD_code "R07.9" ;
                 OpenPVSignal:has_MedDRA_code 10008469 ;
                 OpenPVSignal:has_MedDRA_prefered_term "Chest discomfort" ;
                 rdfs:label "chest discomfort" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#cholecystitis
:cholecystitis rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Adverse_Effect ;
               OpenPVSignal:has_ICD_code "K81.0" ;
               OpenPVSignal:has_MedDRA_code 10008612 ;
               OpenPVSignal:has_MedDRA_prefered_term "Cholecystitis" ;
               rdfs:label "cholecystitis" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#cholestasisIntrahepatic
:cholestasisIntrahepatic rdf:type owl:NamedIndividual ,
                                  OpenPVSignal:Adverse_Effect ;
                         OpenPVSignal:has_ICD_code "K83.1" ;
                         OpenPVSignal:has_MedDRA_code 10008638 ;
                         OpenPVSignal:has_MedDRA_prefered_term "Cholestasis intrahepatic" ;
                         rdfs:label "cholestasis intrahepatic" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#ciprofloxacin
:ciprofloxacin rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Drug ;
               OpenPVSignal:has_ATC_code "J01MA02" ,
                                         "J01RA10" ,
                                         "J01RA11" ,
                                         "J01RA12" ,
                                         "S01AE03" ,
                                         "S02AA15" ,
                                         "S03AA07" ;
               rdfs:label "ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#clonidine
:clonidine rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "C02AC01" ,
                                     "C02LC01" ,
                                     "C02LC51" ,
                                     "N02CX02" ,
                                     "S01EA04" ;
           rdfs:label "clonidine" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#codeine
:codeine rdf:type owl:NamedIndividual ,
                  OpenPVSignal:Drug ;
         OpenPVSignal:has_ATC_code "N02AA59" ,
                                   "N02AA79" ,
                                   "R05DA04" ;
         rdfs:label "codeine" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#codeineAndParacetamol
:codeineAndParacetamol rdf:type owl:NamedIndividual ,
                                OpenPVSignal:Drug ;
                       OpenPVSignal:has_ATC_code "N02AJ06" ;
                       rdfs:label "codeine / paracetamol" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#colecalciferol
:colecalciferol rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Drug ;
                OpenPVSignal:has_ATC_code "A11CC05" ;
                rdfs:label "colecalciferol" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#commonAdrOfVemurafenib
:commonAdrOfVemurafenib rdf:type owl:NamedIndividual ,
                                 OpenPVSignal:Warning_Information ;
                        OpenPVSignal:refers_to_adverse_effect :alopecia ,
                                                              :arthralgia ,
                                                              :cutaneousSquamousCellCarcinoma ,
                                                              :dermatologicalReactions ,
                                                              :fatigue ,
                                                              :hypersensitivity ,
                                                              :liverFunctionTestsAbnormalNos ,
                                                              :melanoma ,
                                                              :nausea ,
                                                              :ophthalmologic_reactions ,
                                                              :photosensitivityReaction ,
                                                              :pruritus ,
                                                              :qtProlonged ,
                                                              :rash ;
                        OpenPVSignal:refers_to_drug :vemurafenib ;
                        mp:references :Ref.1 ;
                        mp:citation "The most common adverse drug reactions (ADR) reported with vemurafenib (>30%) reported with vemurafenib include arthralgia, fatigue, rash, photosensitivity reaction, nausea, alopecia and pruritus. Cutaneous squamous cell carcinoma (CuSCC) was very commonly reported and was most commonly treated by local excision.There are warnings in the product information concerning the possible occurrence of severe hypersensitivity and dermatological reactions, QT prolongation, serious ophthalmologic reactions, new primary melanomas, liver laboratory abnormalities and mild to severe photosensitivity.1" ;
                        rdfs:label "common adr of vemurafenib" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#congestiveHeartFailure
:congestiveHeartFailure rdf:type owl:NamedIndividual ,
                                 OpenPVSignal:Adverse_Effect ;
                        OpenPVSignal:has_ICD_code "I509" ;
                        OpenPVSignal:has_MedDRA_code 10007559 ;
                        OpenPVSignal:has_MedDRA_prefered_term "Cardiac failure congestive" ;
                        rdfs:label "congestive heart failure" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#constipation
:constipation rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Adverse_Effect ;
              OpenPVSignal:has_ICD_code "K590" ;
              OpenPVSignal:has_MedDRA_code 10010774 ;
              OpenPVSignal:has_MedDRA_prefered_term "Constipation" ;
              rdfs:label "constipation" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#creatineBloodIncreased
:creatineBloodIncreased rdf:type owl:NamedIndividual ,
                                 OpenPVSignal:Adverse_Effect ;
                        OpenPVSignal:has_MedDRA_code 10005464 ;
                        OpenPVSignal:has_MedDRA_prefered_term "Blood creatine increased" ;
                        rdfs:label "creatine blood increased" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#creatinineClearanceDecreased
:creatinineClearanceDecreased rdf:type owl:NamedIndividual ,
                                       OpenPVSignal:Adverse_Effect ;
                              OpenPVSignal:has_ICD_code "R944" ;
                              OpenPVSignal:has_MedDRA_code 10011372 ;
                              OpenPVSignal:has_MedDRA_prefered_term "Creatinine renal clearance decreased" ;
                              rdfs:label "creatinine clearance decreased" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#cutaneousSquamousCellCarcinoma
:cutaneousSquamousCellCarcinoma rdf:type owl:NamedIndividual ,
                                         OpenPVSignal:Adverse_Effect ;
                                OpenPVSignal:has_ICD_code "C44.92" ;
                                OpenPVSignal:has_MedDRA_code 10041823 ;
                                OpenPVSignal:has_MedDRA_prefered_term "Squamous cell carcinoma" ;
                                rdfs:label "cutaneous squamous cell carcinoma" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#dasatinib
:dasatinib rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "L01EA02" ;
           rdfs:label "dasatinib" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#dehydration
:dehydration rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Adverse_Effect ;
             OpenPVSignal:has_ICD_code "E860" ;
             OpenPVSignal:has_MedDRA_code 10012174 ;
             OpenPVSignal:has_MedDRA_prefered_term "Dehydration" ;
             rdfs:label "dehydration" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#dermatologicalReactions
:dermatologicalReactions rdf:type owl:NamedIndividual ,
                                  OpenPVSignal:Adverse_Effect ;
                         OpenPVSignal:has_ICD_code "L27.0" ;
                         OpenPVSignal:has_MedDRA_code 10040914 ;
                         OpenPVSignal:has_MedDRA_prefered_term "Skin reaction" ;
                         rdfs:label "dermatological reactions" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#dexamethasone
:dexamethasone rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Drug ;
               OpenPVSignal:has_ATC_code "A01AC02" ,
                                         "C05AA09" ,
                                         "D07AB19" ,
                                         "D07CB04" ,
                                         "D07XB05" ,
                                         "D10AA03" ,
                                         "H02AB02" ,
                                         "R01AD03" ,
                                         "R01AD53" ,
                                         "S01BA01" ,
                                         "S01CA01" ,
                                         "S01CB01" ,
                                         "S02BA06" ,
                                         "S02CA06" ,
                                         "S03BA01" ,
                                         "S03CA01" ;
               rdfs:label "dexamethasone" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#diarrhoea
:diarrhoea rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Adverse_Effect ;
           OpenPVSignal:has_ICD_code "R197" ;
           OpenPVSignal:has_MedDRA_code 10012735 ;
           OpenPVSignal:has_MedDRA_prefered_term "Diarrhoea" ;
           rdfs:label "diarrhoea" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#dimenhydrinate
:dimenhydrinate rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Drug ;
                OpenPVSignal:has_ATC_code "R06AA52" ;
                rdfs:label "dimenhydrinate" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#diphenhydramine
:diphenhydramine rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Drug ;
                 OpenPVSignal:has_ATC_code "D04AA32" ,
                                           "D04AA33" ,
                                           "R06AA02" ,
                                           "R06AA52" ;
                 rdfs:label "diphenhydramine" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#docusate
:docusate rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Drug ;
          OpenPVSignal:has_ATC_code "A06AA02" ,
                                    "A06AG10" ;
          rdfs:label "docusate" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#drugEruption
:drugEruption rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Adverse_Effect ;
              OpenPVSignal:has_MedDRA_code 10013687 ;
              OpenPVSignal:has_MedDRA_prefered_term "Drug eruption" ;
              rdfs:label "drug eruption" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#enoxaparin
:enoxaparin rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "B01AB05" ;
            rdfs:label "enoxaparin" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#ergocalciferol
:ergocalciferol rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Drug ;
                OpenPVSignal:has_ATC_code "A11CC01" ;
                rdfs:label "ergocalciferol" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#erlotinib
:erlotinib rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "L01EB02" ;
           rdfs:label "erlotinib" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#erythema
:erythema rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Adverse_Effect ;
          OpenPVSignal:has_ICD_code "L539" ;
          OpenPVSignal:has_MedDRA_code 10015150 ;
          OpenPVSignal:has_MedDRA_prefered_term "Erythema" ;
          rdfs:label "erythema" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#escitalopram
:escitalopram rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Drug ;
              OpenPVSignal:has_ATC_code "N06AB10" ;
              rdfs:label "escitalopram" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#fatigue
:fatigue rdf:type owl:NamedIndividual ,
                  OpenPVSignal:Adverse_Effect ;
         OpenPVSignal:has_ICD_code "R53" ,
                                   "R5383" ;
         OpenPVSignal:has_MedDRA_code 10016256 ;
         OpenPVSignal:has_MedDRA_prefered_term "Fatigue" ;
         rdfs:label "fatigue" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#felodopine
:felodopine rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "C08CA01" ;
            rdfs:label "felodopine" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#fentanyl
:fentanyl rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Drug ;
          OpenPVSignal:has_ATC_code "N01AH01" ,
                                    "N01AH51" ,
                                    "N02AB03" ;
          rdfs:label "fentanyl" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#fever
:fever rdf:type owl:NamedIndividual ,
                OpenPVSignal:Adverse_Effect ;
       OpenPVSignal:has_ICD_code "R509" ;
       OpenPVSignal:has_MedDRA_code 10037660 ;
       OpenPVSignal:has_MedDRA_prefered_term "Pyrexia" ;
       rdfs:label "fever" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#finasteride
:finasteride rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "D11AX10" ,
                                       "G04CA51" ,
                                       "G04CB01" ;
             rdfs:label "finasteride" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#furosemide
:furosemide rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "C03CA01" ,
                                      "C03CB01" ,
                                      "C03EB01" ,
                                      "G01AE10" ;
            rdfs:label "furosemide" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#glipizide
:glipizide rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "A10BB07" ;
           rdfs:label "glipizide" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#headache
:headache rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Adverse_Effect ;
          OpenPVSignal:has_ICD_code "R51" ;
          OpenPVSignal:has_MedDRA_code 10019211 ;
          OpenPVSignal:has_MedDRA_prefered_term "Headache" ;
          rdfs:label "headache" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#hepaticFailure
:hepaticFailure rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Adverse_Effect ;
                OpenPVSignal:has_ICD_code "K72" ;
                OpenPVSignal:has_MedDRA_code 10019663 ;
                OpenPVSignal:has_MedDRA_prefered_term "Hepatic failure" ;
                rdfs:label "hepatic failure" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#hepaticFunctionAbnormal
:hepaticFunctionAbnormal rdf:type owl:NamedIndividual ,
                                  OpenPVSignal:Adverse_Effect ;
                         OpenPVSignal:has_ICD_code "R945" ;
                         OpenPVSignal:has_MedDRA_code 10019670 ;
                         OpenPVSignal:has_MedDRA_prefered_term "Hepatic function abnormal" ;
                         rdfs:label "hepatic function abnormal" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#hydrochlorothiazide
:hydrochlorothiazide rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Drug ;
                     OpenPVSignal:has_ATC_code "C03AA03" ,
                                               "C03AB03" ,
                                               "C03AX01" ,
                                               "C03EA01" ,
                                               "C09DX01" ,
                                               "C09DX03" ,
                                               "C09XA52" ,
                                               "C09XA54" ,
                                               "G01AE10" ;
                     rdfs:label "hydrochlorothiazide" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#hydrocortisone
:hydrocortisone rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Drug ;
                OpenPVSignal:has_ATC_code "A01AC03" ,
                                          "A07EA02" ,
                                          "C05AA01" ,
                                          "D07AA02" ,
                                          "D07AB02" ,
                                          "D07AC16" ,
                                          "D07BA04" ,
                                          "D07BB04" ,
                                          "D07CA01" ,
                                          "D07XA01" ,
                                          "H02AB09" ,
                                          "R01AD60" ,
                                          "S01BA02" ,
                                          "S01BB01" ,
                                          "S01CA03" ,
                                          "S01CB03" ,
                                          "S02BA01" ,
                                          "S02CA03" ,
                                          "S03CA04" ;
                rdfs:label "hydrocortisone" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#hyperkalaemia
:hyperkalaemia rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Adverse_Effect ;
               OpenPVSignal:has_ICD_code "E875" ;
               OpenPVSignal:has_MedDRA_code 10020646 ;
               OpenPVSignal:has_MedDRA_prefered_term "Hyperkalaemia" ;
               rdfs:label "hyperkalaemia" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#hypersensitivity
:hypersensitivity rdf:type owl:NamedIndividual ,
                           OpenPVSignal:Adverse_Effect ;
                  OpenPVSignal:has_ICD_code "T78.40XA" ;
                  OpenPVSignal:has_MedDRA_code 10020751 ;
                  OpenPVSignal:has_MedDRA_prefered_term "Hypersensitivity" ;
                  rdfs:label "hypersensitivity" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#hypokinesia
:hypokinesia rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Adverse_Effect ;
             OpenPVSignal:has_ICD_code "T50901A" ;
             OpenPVSignal:has_MedDRA_code 10021021 ;
             OpenPVSignal:has_MedDRA_prefered_term "Hypokinesia" ;
             rdfs:label "hypokinesia" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#hypolipidaemics
:hypolipidaemics rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Drug ;
                 OpenPVSignal:has_ATC_code "G03FA11" ;
                 rdfs:label "hypolipidaemics" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#hyponatraemia
:hyponatraemia rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Adverse_Effect ;
               OpenPVSignal:has_ICD_code "E871" ;
               OpenPVSignal:has_MedDRA_code 10021036 ;
               OpenPVSignal:has_MedDRA_prefered_term "Hyponatraemia" ;
               rdfs:label "hyponatraemia" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#hypophagia
:hypophagia rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Adverse_Effect ;
            OpenPVSignal:has_MedDRA_code 10063743 ;
            OpenPVSignal:has_MedDRA_prefered_term "Hypophagia" ;
            rdfs:label "hypophagia" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#hypotension
:hypotension rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Adverse_Effect ;
             OpenPVSignal:has_ICD_code "I959" ;
             OpenPVSignal:has_MedDRA_code 10021097 ;
             OpenPVSignal:has_MedDRA_prefered_term "Hypotension" ;
             rdfs:label "hypotension" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#hypotensive
:hypotensive rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Adverse_Effect ;
             OpenPVSignal:has_ICD_code "I959" ;
             OpenPVSignal:has_MedDRA_code 10021097 ;
             OpenPVSignal:has_MedDRA_prefered_term "Hypotension" ;
             rdfs:label "hypotensive" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#hypovolaemia
:hypovolaemia rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Adverse_Effect ;
              OpenPVSignal:has_ICD_code "E86.1" ;
              OpenPVSignal:has_MedDRA_code 10021137 ;
              OpenPVSignal:has_MedDRA_prefered_term "Hypovolaemia" ;
              rdfs:label "hypovolaemia" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#ibuprofen
:ibuprofen rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "C01EB16" ,
                                     "G02CC01" ,
                                     "M01AE01" ,
                                     "M01AE51" ,
                                     "M02AA13" ,
                                     "R02AX02" ;
           rdfs:label "ibuprofen" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#imatinib
:imatinib rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Drug ;
          OpenPVSignal:has_ATC_code "L01EA01" ;
          rdfs:label "imatinib" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#imipenem
:imipenem rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Drug ;
          OpenPVSignal:has_ATC_code "J01DH51" ;
          rdfs:label "imipenem" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#infection
:infection rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Adverse_Effect ;
           OpenPVSignal:has_ICD_code "A499" ;
           OpenPVSignal:has_MedDRA_code 10021789 ;
           OpenPVSignal:has_MedDRA_prefered_term "Infection" ;
           rdfs:label "infection" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#infoForFatalReports
:infoForFatalReports rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Case_Report_Information ;
                     OpenPVSignal:belongs_to_reports_group :reportsWithFatalOutcome ;
                     OpenPVSignal:has_content "The reason for death in one case was renal failure, hepatic failure and sepsis while in the other case, renal failure was stated to be contributory to the death" ;
                     rdfs:label "info for fatal reports" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#iodine
:iodine rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Drug ;
        OpenPVSignal:has_ATC_code "D08AG03" ;
        rdfs:label "iodine" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#irbesartan
:irbesartan rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "C09CA04" ,
                                      "C09DA04" ,
                                      "C09DB05" ;
            rdfs:label "irbesartan" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#iron
:iron rdf:type owl:NamedIndividual ,
               OpenPVSignal:Drug ;
      OpenPVSignal:has_ATC_code "A11AA01" ,
                                "B03AA01" ,
                                "B03AA02" ,
                                "B03AA03" ,
                                "B03AA06" ,
                                "B03AA10" ,
                                "B03AD02" ,
                                "B03AE01" ,
                                "B03AE02" ,
                                "B03AE03" ,
                                "B03AE04" ;
      rdfs:label "iron" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#itching
:itching rdf:type owl:NamedIndividual ,
                  OpenPVSignal:Adverse_Effect ;
         OpenPVSignal:has_ICD_code "L29" ,
                                   "L299" ;
         OpenPVSignal:has_MedDRA_code 10037087 ;
         OpenPVSignal:has_MedDRA_prefered_term "Pruritus" ;
         rdfs:label "itching" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#jointPain
:jointPain rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Adverse_Effect ;
           OpenPVSignal:has_ICD_code "M2550" ;
           OpenPVSignal:has_MedDRA_code 10023222 ;
           OpenPVSignal:has_MedDRA_prefered_term "Joint pain" ;
           rdfs:label "joint pain" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#keratocanthoma
:keratocanthoma rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Adverse_Effect ;
                OpenPVSignal:has_ICD_code "L85.8" ;
                OpenPVSignal:has_MedDRA_code 10023347 ;
                OpenPVSignal:has_MedDRA_prefered_term "Keratoacanthoma" ;
                rdfs:label "keratocanthoma" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#keratosis
:keratosis rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Adverse_Effect ;
           OpenPVSignal:has_ICD_code "L859" ;
           OpenPVSignal:has_MedDRA_code 10023368 ;
           OpenPVSignal:has_MedDRA_prefered_term "Keratosis" ;
           rdfs:label "keratosis" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#laboratoryTestFalse
:laboratoryTestFalse rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Adverse_Effect ;
                     rdfs:label "laboratory test false" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#lactulose
:lactulose rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "A06AD11" ,
                                     "A06AD61" ;
           rdfs:label "lactulose" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#lansoprazole
:lansoprazole rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Drug ;
              OpenPVSignal:has_ATC_code "A02BC03" ,
                                        "A02BC53" ,
                                        "A02BD02" ,
                                        "A02BD03" ,
                                        "A02BD07" ,
                                        "A02BD09" ,
                                        "A02BD10" ;
              rdfs:label "lansoprazole" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#legPain
:legPain rdf:type owl:NamedIndividual ,
                  OpenPVSignal:Adverse_Effect ;
         OpenPVSignal:has_ICD_code "M79606" ;
         OpenPVSignal:has_MedDRA_code 10024130 ;
         OpenPVSignal:has_MedDRA_prefered_term "Leg pain" ;
         rdfs:label "leg pain" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#levothyroxine
:levothyroxine rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Drug ;
               OpenPVSignal:has_ATC_code "H03AA01" ;
               rdfs:label "levothyroxine" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#lisinopril
:lisinopril rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "C09AA03" ,
                                      "C09BA03" ,
                                      "C09BB03" ,
                                      "C10BX07" ;
            rdfs:label "lisinopril" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#liverFunctionAbnormal
:liverFunctionAbnormal rdf:type owl:NamedIndividual ,
                                OpenPVSignal:Adverse_Effect ;
                       OpenPVSignal:has_ICD_code "R945" ;
                       OpenPVSignal:has_MedDRA_code 10019670 ;
                       OpenPVSignal:has_MedDRA_prefered_term "Hepatic function abnormal" ;
                       rdfs:label "liver function abnormal" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#liverFunctionTestsAbnormalNos
:liverFunctionTestsAbnormalNos rdf:type owl:NamedIndividual ,
                                        OpenPVSignal:Adverse_Effect ;
                               OpenPVSignal:has_ICD_code "R945" ;
                               OpenPVSignal:has_MedDRA_code 10024690 ;
                               OpenPVSignal:has_MedDRA_prefered_term "Liver function test abnormal" ;
                               rdfs:label "liver function tests abnormal nos" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#lovastatin
:lovastatin rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "C10AA02" ,
                                      "C10BA01" ;
            rdfs:label "lovastatin" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#lungOedema
:lungOedema rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Adverse_Effect ;
            OpenPVSignal:has_ICD_code "J810" ;
            OpenPVSignal:has_MedDRA_code 10037423 ;
            OpenPVSignal:has_MedDRA_prefered_term "Pulmonary oedema" ;
            rdfs:label "lung oedema" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#lymphoedema
:lymphoedema rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Adverse_Effect ;
             OpenPVSignal:has_ICD_code "I89.0" ;
             OpenPVSignal:has_MedDRA_code 10025282 ;
             OpenPVSignal:has_MedDRA_prefered_term "Lymphoedema" ;
             rdfs:label "lymphoedema" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#magnesiumOxide
:magnesiumOxide rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Drug ;
                OpenPVSignal:has_ATC_code "A02AA02" ,
                                          "A06AD02" ,
                                          "A12CC10" ;
                rdfs:label "magnesium oxide" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#melanoma
:melanoma rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Adverse_Effect ;
          OpenPVSignal:has_MedDRA_code 10053571 ;
          OpenPVSignal:has_MedDRA_prefered_term "Melanoma" ;
          rdfs:label "melanoma" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#meropenem
:meropenem rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "J01DH02" ;
           rdfs:label "meropenem" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#metamizole
:metamizole rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "N02BB02" ,
                                      "N02BB52" ,
                                      "N02BB72" ;
            rdfs:label "metamizole" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#metastasesNos
:metastasesNos rdf:type owl:NamedIndividual ,
                        OpenPVSignal:Adverse_Effect ;
               OpenPVSignal:has_ICD_code "C79.9" ;
               OpenPVSignal:has_MedDRA_code 10062194 ;
               OpenPVSignal:has_MedDRA_prefered_term "Metastasis" ;
               rdfs:label "metastases nos" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#metformin
:metformin rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "A10BA02" ,
                                     "A10BD02" ,
                                     "A10BD03" ,
                                     "A10BD05" ,
                                     "A10BD07" ,
                                     "A10BD08" ,
                                     "A10BD10" ,
                                     "A10BD11" ,
                                     "A10BD13" ,
                                     "A10BD14" ,
                                     "A10BD15" ,
                                     "A10BD16" ,
                                     "A10BD17" ,
                                     "A10BD18" ,
                                     "A10BD20" ;
           rdfs:label "metformin" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#methylprednisolone
:methylprednisolone rdf:type owl:NamedIndividual ,
                             OpenPVSignal:Drug ;
                    OpenPVSignal:has_ATC_code "D07AA01" ,
                                              "D07AC14" ,
                                              "D07CA02" ,
                                              "D10AA02" ,
                                              "H02AB04" ,
                                              "H02BX01" ,
                                              "S01CA08" ;
                    rdfs:label "methylprednisolone" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#metoclopramide
:metoclopramide rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Drug ;
                OpenPVSignal:has_ATC_code "A03FA01" ;
                rdfs:label "metoclopramide" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#metolazone
:metolazone rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "C03BA08" ,
                                      "C03EA12" ,
                                      "G01AE10" ;
            rdfs:label "metolazone" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#metoprolol
:metoprolol rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "C07AB02" ,
                                      "C07AB52" ,
                                      "C07BB02" ,
                                      "C07BB52" ,
                                      "C07CB02" ,
                                      "C07FB02" ;
            rdfs:label "metoprolol" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#milrinone
:milrinone rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "C01CE02" ;
           rdfs:label "milrinone" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#molsidomine
:molsidomine rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "C01DX12" ;
             rdfs:label "molsidomine" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#muscleAche
:muscleAche rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Adverse_Effect ;
            OpenPVSignal:has_ICD_code "M791" ;
            OpenPVSignal:has_MedDRA_code 10028287 ;
            OpenPVSignal:has_MedDRA_prefered_term "Muscle ache" ;
            rdfs:label "muscle ache" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#myalgia
:myalgia rdf:type owl:NamedIndividual ,
                  OpenPVSignal:Adverse_Effect ;
         OpenPVSignal:has_ICD_code "M791" ;
         OpenPVSignal:has_MedDRA_code 10028411 ;
         OpenPVSignal:has_MedDRA_prefered_term "Myalgia" ;
         rdfs:label "myalgia" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#nadolol
:nadolol rdf:type owl:NamedIndividual ,
                  OpenPVSignal:Drug ;
         OpenPVSignal:has_ATC_code "C07AA12" ,
                                   "C07BA12" ;
         rdfs:label "nadolol" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#naproxen
:naproxen rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Drug ;
          OpenPVSignal:has_ATC_code "G02CC02" ,
                                    "M01AE02" ,
                                    "M01AE52" ,
                                    "M01AE56" ,
                                    "M02AA12" ;
          rdfs:label "naproxen" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#nausea
:nausea rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Adverse_Effect ;
        OpenPVSignal:has_ICD_code "R11" ;
        OpenPVSignal:has_MedDRA_code 10028813 ;
        OpenPVSignal:has_MedDRA_prefered_term "Nausea" ;
        rdfs:label "nausea" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#nifedipine
:nifedipine rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "C08CA05" ,
                                      "C08CA55" ,
                                      "C08GA01" ;
            rdfs:label "nifedipine" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#nilotinib
:nilotinib rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "L01EA03" ;
           rdfs:label "nilotinib" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#nystatin
:nystatin rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Drug ;
          OpenPVSignal:has_ATC_code "A07AA02" ,
                                    "D01AA01" ,
                                    "G01AA01" ,
                                    "G01AA51" ;
          rdfs:label "nystatin" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#oedema
:oedema rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Adverse_Effect ;
        OpenPVSignal:has_ICD_code "R609" ;
        OpenPVSignal:has_MedDRA_code 10030095 ;
        OpenPVSignal:has_MedDRA_prefered_term "Oedema" ;
        rdfs:label "oedema" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#olmesartan
:olmesartan rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "C09CA08" ,
                                      "C09DA08" ,
                                      "C09DB02" ,
                                      "C09DX03" ;
            rdfs:label "olmesartan" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#omeprazole
:omeprazole rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "A02BC01" ,
                                      "A02BD01" ,
                                      "A02BD05" ;
            rdfs:label "omeprazole" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#ondansetron
:ondansetron rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "A04AA01" ;
             rdfs:label "ondansetron" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#ophthalmologic_reactions
:ophthalmologic_reactions rdf:type owl:NamedIndividual ,
                                   OpenPVSignal:Adverse_Effect ;
                          OpenPVSignal:has_MedDRA_code 10015919 ;
                          OpenPVSignal:has_MedDRA_prefered_term "Eye disorders" ;
                          rdfs:label "ophthalmologic reactions" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#oral_administration
:oral_administration rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Drug_Intake_Form ;
                     OpenPVSignal:refers_to_drug :vemurafenib ;
                     OpenPVSignal:refers_to_form_of_intake "oral" ;
                     rdfs:label "oral administration" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#oxycodone
:oxycodone rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "N02AA05" ,
                                     "N02AJ17" ;
           rdfs:label "oxycodone" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#pancreatitis
:pancreatitis rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Adverse_Effect ;
              OpenPVSignal:has_ICD_code "K85" ;
              OpenPVSignal:has_MedDRA_code 10033645 ;
              OpenPVSignal:has_MedDRA_prefered_term "Pancreatitis" ;
              rdfs:label "pancreatitis" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#pantoprazole
:pantoprazole rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Drug ;
              OpenPVSignal:has_ATC_code "A02BC02" ,
                                        "A02BD04" ,
                                        "A02BD11" ;
              rdfs:label "pantoprazole" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#paracetamol
:paracetamol rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "N02BE01" ;
             rdfs:label "paracetamol" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#paraesthesia
:paraesthesia rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Adverse_Effect ;
              OpenPVSignal:has_ICD_code "R202" ;
              OpenPVSignal:has_MedDRA_code 10033775 ;
              OpenPVSignal:has_MedDRA_prefered_term "Paraesthesia" ;
              rdfs:label "paraesthesia" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#paroxetine
:paroxetine rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "N06AB05" ;
            rdfs:label "paroxetine" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#perindopril
:perindopril rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "C09AA04" ,
                                       "C09BA04" ,
                                       "C09BB04" ,
                                       "C09BX01" ,
                                       "C09BX02" ,
                                       "C10BX11" ;
             rdfs:label "perindopril" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#photosensitivityReaction
:photosensitivityReaction rdf:type owl:NamedIndividual ,
                                   OpenPVSignal:Adverse_Effect ;
                          OpenPVSignal:has_ICD_code "L568" ;
                          OpenPVSignal:has_MedDRA_code 10034972 ;
                          OpenPVSignal:has_MedDRA_prefered_term "Photosensitivity reaction" ;
                          rdfs:label "photosensitivity reaction" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#phytomenadione
:phytomenadione rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Drug ;
                OpenPVSignal:has_ATC_code "B02BA01" ;
                rdfs:label "phytomenadione" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#pioglitazone
:pioglitazone rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Drug ;
              OpenPVSignal:has_ATC_code "A10BD05" ,
                                        "A10BD06" ,
                                        "A10BD09" ,
                                        "A10BD12" ,
                                        "A10BG03" ;
              rdfs:label "pioglitazone" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#pleuralEffusion
:pleuralEffusion rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Adverse_Effect ;
                 OpenPVSignal:has_ICD_code "J90" ;
                 OpenPVSignal:has_MedDRA_code 10035598 ;
                 OpenPVSignal:has_MedDRA_prefered_term "Pleural effusion" ;
                 rdfs:label "pleural effusion" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#pneumonia
:pneumonia rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Adverse_Effect ;
           OpenPVSignal:has_ICD_code "J158" ;
           OpenPVSignal:has_MedDRA_code 10035664 ;
           OpenPVSignal:has_MedDRA_prefered_term "Pneumonia" ;
           rdfs:label "pneumonia" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#potassium
:potassium rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "B05XA17" ,
                                     "C03AB01" ,
                                     "C03AB02" ,
                                     "C03AB03" ,
                                     "C03AB04" ,
                                     "C03AB05" ,
                                     "C03AB06" ,
                                     "C03AB07" ,
                                     "C03AB08" ,
                                     "C03AB09" ,
                                     "C03BB02" ,
                                     "C03BB03" ,
                                     "C03BB04" ,
                                     "C03BB05" ,
                                     "C03BB07" ,
                                     "C03CB01" ,
                                     "C03CB02" ;
           rdfs:label "potassium" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#prazosin
:prazosin rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Drug ;
          OpenPVSignal:has_ATC_code "C02CA01" ,
                                    "C02LE01" ;
          rdfs:label "prazosin" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#prednisolone
:prednisolone rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Drug ;
              OpenPVSignal:has_ATC_code "A01AC54" ,
                                        "A07EA01" ,
                                        "C05AA04" ,
                                        "D07AA03" ,
                                        "D07BA01" ,
                                        "D07CA03" ,
                                        "D07XA02" ,
                                        "H02AB06" ,
                                        "R01AD02" ,
                                        "R01AD52" ,
                                        "S01BA04" ,
                                        "S01BB02" ,
                                        "S01CA02" ,
                                        "S01CB02" ,
                                        "S02BA03" ,
                                        "S02CA01" ,
                                        "S03BA02" ,
                                        "S03CA02" ,
                                        "V03AB05" ;
              rdfs:label "prednisolone" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#pregabalin
:pregabalin rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "N03AX16" ;
            rdfs:label "pregabalin" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#product_info
:product_info rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Structured_Product_Labels_information ;
              OpenPVSignal:refers_to_drug :vemurafenib ;
              mp:references :Ref.1 ;
              OpenPVSignal:has_content "The product literature does not refer to renal failure or any other renal reaction1 . There is a warning in the product information regarding renal impairment which indicates that no adjustment to the starting dose is needed for patients with mild or moderate renal impairment. There are only limited data available in patients with severe renal impairment. Vemurafenib should be used with caution in patients with severe renal impairment and patients should be closely monitored1." ;
              rdfs:label "product info" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#promethazine
:promethazine rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Drug ;
              OpenPVSignal:has_ATC_code "D04AA10" ,
                                        "R06AD02" ,
                                        "R06AD52" ,
                                        "V03AB05" ;
              rdfs:label "promethazine" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#propranolol
:propranolol rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "C07AA05" ,
                                       "C07BA05" ,
                                       "C07FA05" ;
             rdfs:label "propranolol" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#propylene_glycol
:propylene_glycol rdf:type owl:NamedIndividual ,
                           OpenPVSignal:Drug ;
                  OpenPVSignal:has_ATC_code "QA16QA01" ;
                  rdfs:label "propylene glycol" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#protonPumpInhibitors
:protonPumpInhibitors rdf:type owl:NamedIndividual ,
                               OpenPVSignal:Drug ;
                      OpenPVSignal:has_ATC_code "A02BCÂ " ;
                      rdfs:label "proton pump inhibitors" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#pruritus
:pruritus rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Adverse_Effect ;
          OpenPVSignal:has_MedDRA_code 10037087 ;
          OpenPVSignal:has_MedDRA_prefered_term "Pruritus" ;
          rdfs:label "pruritus" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#pvSignal
:pvSignal rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Signal ;
          OpenPVSignal:Free_text_reporting_element :DiscussionAndConclusion ,
                                                   :IntroductionContent ,
                                                   :ReportsInVigibase ,
                                                   :SummaryContent ,
                                                   :renal_failure_pathophysiology ;
          OpenPVSignal:is_supported_by_individual_case_report :Report1 ,
                                                              :Report10 ,
                                                              :Report11 ,
                                                              :Report12 ,
                                                              :Report13 ,
                                                              :Report14 ,
                                                              :Report15 ,
                                                              :Report16 ,
                                                              :Report17 ,
                                                              :Report18 ,
                                                              :Report19 ,
                                                              :Report2 ,
                                                              :Report20 ,
                                                              :Report21 ,
                                                              :Report22 ,
                                                              :Report23 ,
                                                              :Report24 ,
                                                              :Report25 ,
                                                              :Report26 ,
                                                              :Report27 ,
                                                              :Report28 ,
                                                              :Report29 ,
                                                              :Report3 ,
                                                              :Report30 ,
                                                              :Report31 ,
                                                              :Report32 ,
                                                              :Report33 ,
                                                              :Report34 ,
                                                              :Report35 ,
                                                              :Report36 ,
                                                              :Report37 ,
                                                              :Report38 ,
                                                              :Report39 ,
                                                              :Report4 ,
                                                              :Report40 ,
                                                              :Report41 ,
                                                              :Report5 ,
                                                              :Report6 ,
                                                              :Report7 ,
                                                              :Report8 ,
                                                              :Report9 ;
          OpenPVSignal:is_supported_by_statistical_entity :IC025_for_vemurafenib_and_ARF ,
                                                          :IC025_for_vemurafenib_and_CRF ,
                                                          :IC025_for_vemurafenib_and_renal_failure_aggravated ,
                                                          :IC_for_vemurafenib_and_ARF ,
                                                          :IC_for_vemurafenib_and_CRF ,
                                                          :IC_for_vemurafenib_and_renal_failure_aggravated ,
                                                          :ReportsFromAustralia ,
                                                          :ReportsFromAustria ,
                                                          :ReportsFromBelgium ,
                                                          :ReportsFromCanada ,
                                                          :ReportsFromGermany ,
                                                          :ReportsFromGreece ,
                                                          :ReportsFromItaly ,
                                                          :ReportsFromNetherladnds ,
                                                          :ReportsFromSweden ,
                                                          :ReportsFromSwitzerland ,
                                                          :ReportsFromUnitedKingdom ,
                                                          :ReportsFromUnitedStates ,
                                                          :reportsAfterEliminationOfDuplicates ,
                                                          :reportsWithFatalOutcome ,
                                                          :reportsWithNegativeRechallenge ,
                                                          :reportsWithNoRecovery ,
                                                          :reportsWithNoWithdrawal ,
                                                          :reportsWithPartialDechallenge ,
                                                          :reportsWithPositiveDechallenge ,
                                                          :reportsWithPositiveRechallenge ,
                                                          :reportsWithRecoveryAsOutcome ,
                                                          :reportsWithTimeToOnset ,
                                                          :reportsWithVemurafenibAndARF ,
                                                          :reportsWithVemurafenibAndCRF ,
                                                          :reportsWithVemurafenibAndRenalFailureAggrevated ,
                                                          :reportsWithWithdrawal ;
          OpenPVSignal:refers_to_adverse_effect :renalFailure ;
          OpenPVSignal:refers_to_drug :vemurafenib ;
          OpenPVSignal:refers_to_primary_suspect_drug :vemurafenib ;
          mp:supportedByData :Fatal_case_of_renal_failure_in_patient_with_vemurafenib ,
                             :Renal_toxicity_of_TKIs ,
                             :commonAdrOfVemurafenib ,
                             :product_info ;
          OpenPVSignal:initially_identified_on "01/07/2014" ;
          rdfs:label "pv signal" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#pyrexia
:pyrexia rdf:type owl:NamedIndividual ,
                  OpenPVSignal:Adverse_Effect ;
         OpenPVSignal:has_ICD_code "R509" ;
         OpenPVSignal:has_MedDRA_code 10037660 ;
         OpenPVSignal:has_MedDRA_prefered_term "Pyrexia" ;
         rdfs:label "pyrexia" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#qtProlonged
:qtProlonged rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Adverse_Effect ;
             OpenPVSignal:has_ICD_code "I4581" ;
             OpenPVSignal:has_MedDRA_code 10014387 ;
             OpenPVSignal:has_MedDRA_prefered_term "Electrocardiogram QT prolonged" ;
             rdfs:label "qt prolonged" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#ramipril
:ramipril rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Drug ;
          OpenPVSignal:has_ATC_code "C09AA05" ,
                                    "C09BA05" ,
                                    "C09BB05" ,
                                    "C09BB07" ,
                                    "C10BX04" ,
                                    "C10BX06" ;
          rdfs:label "ramipril" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#ranitidine
:ranitidine rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "A02BA02" ,
                                      "A02BA07" ;
            rdfs:label "ranitidine" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#rash
:rash rdf:type owl:NamedIndividual ,
               OpenPVSignal:Adverse_Effect ;
      OpenPVSignal:has_ICD_code "R21" ;
      OpenPVSignal:has_MedDRA_code 10037844 ;
      OpenPVSignal:has_MedDRA_prefered_term "Rash" ;
      rdfs:label "rash" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#rashErythematous
:rashErythematous rdf:type owl:NamedIndividual ,
                           OpenPVSignal:Adverse_Effect ;
                  OpenPVSignal:has_ICD_code "L539" ;
                  OpenPVSignal:has_MedDRA_code 10037855 ;
                  OpenPVSignal:has_MedDRA_prefered_term "Rash erythematous" ;
                  rdfs:label "rash erythematous" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#rashmaculo-papular
:rashmaculo-papular rdf:type owl:NamedIndividual ,
                             OpenPVSignal:Adverse_Effect ;
                    OpenPVSignal:has_ICD_code "L30.9" ;
                    OpenPVSignal:has_MedDRA_code 10037868 ;
                    OpenPVSignal:has_MedDRA_prefered_term "Rash maculo-papular" ;
                    rdfs:label "rash maculo-papular" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#renalFailure
:renalFailure rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Adverse_Effect ;
              OpenPVSignal:has_ICD_code "N189" ;
              OpenPVSignal:has_MedDRA_code 10038435 ;
              OpenPVSignal:has_MedDRA_prefered_term "Renal failure" ;
              rdfs:label "renal failure" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#renalFailureAcute
:renalFailureAcute rdf:type owl:NamedIndividual ,
                            OpenPVSignal:Adverse_Effect ;
                   OpenPVSignal:has_ICD_code "N179" ;
                   OpenPVSignal:has_MedDRA_code 10069339 ;
                   OpenPVSignal:has_MedDRA_prefered_term "Acute kidney injury" ;
                   rdfs:label "renal failure acute" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#renalFailureAggravated
:renalFailureAggravated rdf:type owl:NamedIndividual ,
                                 OpenPVSignal:Adverse_Effect ;
                        OpenPVSignal:has_ICD_code "N189" ;
                        OpenPVSignal:has_MedDRA_code 10038442 ;
                        OpenPVSignal:has_MedDRA_prefered_term "Renal failure aggravated" ;
                        rdfs:label "renal failure aggravated" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#renalFailureChronic
:renalFailureChronic rdf:type owl:NamedIndividual ,
                              OpenPVSignal:Adverse_Effect ;
                     OpenPVSignal:has_ICD_code "N189" ;
                     OpenPVSignal:has_MedDRA_code 10064848 ;
                     OpenPVSignal:has_MedDRA_prefered_term "Chronic kidney disease" ;
                     rdfs:label "renal failure chronic" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#renalFunctionAbnormal
:renalFunctionAbnormal rdf:type owl:NamedIndividual ,
                                OpenPVSignal:Adverse_Effect ;
                       OpenPVSignal:has_ICD_code "N18.9" ;
                       OpenPVSignal:has_MedDRA_code 10038451 ;
                       OpenPVSignal:has_MedDRA_prefered_term "Renal function abnormal" ;
                       rdfs:label "renal function abnormal" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#renal_failure_pathophysiology
:renal_failure_pathophysiology rdf:type owl:NamedIndividual ,
                                        OpenPVSignal:Free_text_reporting_element ;
                               OpenPVSignal:refers_to_adverse_effect :renalFailure ,
                                                                     :renalFailureAcute ;
                               mp:references :Ref.2 ,
                                             :Ref.3 ;
                               OpenPVSignal:has_content "Renal failure is a reduction or suppression of the excretory function of the kidney, characterized by a decrease in creatinine clearance.2 Renal failure is demonstrated by an increase in serum creatinine above 150 mmol/L, or reduction in creatinine clearance below 50 mL/ min per 1.73 m 2 of body surface. Age, sex, weight and whether the patient is pregnant should be considered in determining abnormality of levels of serum creatinine or creatinine clearance. The presenting symptoms of drug-induced renal failure are the same as those for renal failure due to other causes. Drugs can cause renal failure, which may be acute (developing within hours or days), subacute (within weeks), or chronic (within months or years); they may also exacerbate pre-existing renal failure. Whenever possible in reporting a suspected adverse drug reaction, the pre-existing level of renal function should be included in addition to the actual change in function.2 The cause of acute renal failure (ARF) can be characterised based on where the injury has occurred.3 Pre-renal causes include hypovolaemia, dehydration due to vomiting, diarrhoea, sweating or fever, poor intake of fluids, medications such as diureticâ€™s and abnormal blood flow due to obstruction. Renal causes include sepsis, medications such as NSAIDs, antibiotics such as aminoglycosides, lithium and iodine, rhabdomyolysis, multiple myeloma and glomerulonephritis. Post-renal causes include obstruction of the bladder or the ureters, prostatic hypertrophy or prostate cancer, abdominal tumours or kidney stones. The most common causes of chronic renal failure (CRF) are poorly controlled diabetes, poorly controlled hypertension and chronic glomerulonephritis. Other causes include polycystic kidney disease, reflux nephropathy, kidney stones and prostate disease.3" ;
                               rdfs:label "renal failure pathophysiology" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#reportsAfterEliminationOfDuplicates
:reportsAfterEliminationOfDuplicates rdf:type owl:NamedIndividual ,
                                              OpenPVSignal:Reports_group ;
                                     OpenPVSignal:refers_to_adverse_effect :renalFailureAcute ,
                                                                           :renalFailureChronic ;
                                     OpenPVSignal:refers_to_primary_suspect_drug :vemurafenib ;
                                     OpenPVSignal:has_count 38 ;
                                     OpenPVSignal:has_count_of_men 22 ;
                                     OpenPVSignal:has_count_of_women 13 ;
                                     OpenPVSignal:has_max_age "89.0"^^xsd:float ;
                                     OpenPVSignal:has_min_age "38.0"^^xsd:float ;
                                     OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                     rdfs:label "overall reports after elimination of duplicates" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#reportsWithFatalOutcome
:reportsWithFatalOutcome rdf:type owl:NamedIndividual ,
                                  OpenPVSignal:Reports_group ;
                         OpenPVSignal:is_subgroup_of :reportsAfterEliminationOfDuplicates ;
                         OpenPVSignal:has_count 2 ;
                         OpenPVSignal:refers_to_database "WHO Vigibase" ;
                         OpenPVSignal:refers_to_outcome_after_action "death" ;
                         rdfs:label "reports with fatal outcome" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#reportsWithNegativeRechallenge
:reportsWithNegativeRechallenge rdf:type owl:NamedIndividual ,
                                         OpenPVSignal:Reports_group ;
                                OpenPVSignal:is_subgroup_of :reportsWithPositiveDechallenge ;
                                OpenPVSignal:has_count 1 ;
                                OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                OpenPVSignal:refers_to_rechallenge_outcome "negative rechallenge - condition not appeared" ;
                                rdfs:label "reports with negative rechallenge" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#reportsWithNoRecovery
:reportsWithNoRecovery rdf:type owl:NamedIndividual ,
                                OpenPVSignal:Reports_group ;
                       OpenPVSignal:is_subgroup_of :reportsAfterEliminationOfDuplicates ;
                       OpenPVSignal:has_count 7 ;
                       OpenPVSignal:refers_to_database "WHO Vigibase" ;
                       OpenPVSignal:refers_to_outcome_after_action "no recovery" ;
                       rdfs:label "reports with no recovery" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#reportsWithNoWithdrawal
:reportsWithNoWithdrawal rdf:type owl:NamedIndividual ,
                                  OpenPVSignal:Reports_group ;
                         OpenPVSignal:is_subgroup_of :reportsWithNoRecovery ;
                         OpenPVSignal:has_count 1 ;
                         OpenPVSignal:refers_to_database "WHO Vigibase" ;
                         OpenPVSignal:refers_to_dechallenge_process "false"^^xsd:boolean ;
                         rdfs:label "reports with no withdrawal" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#reportsWithPartialDechallenge
:reportsWithPartialDechallenge rdf:type owl:NamedIndividual ,
                                        OpenPVSignal:Reports_group ;
                               OpenPVSignal:is_subgroup_of :reportsWithNoRecovery ;
                               OpenPVSignal:has_count 1 ;
                               OpenPVSignal:refers_to_database "WHO Vigibase" ;
                               OpenPVSignal:refers_to_partial_dechallenge_outcome "negative - condition still applied" ;
                               rdfs:label "reports with partial dechallenge" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#reportsWithPositiveDechallenge
:reportsWithPositiveDechallenge rdf:type owl:NamedIndividual ,
                                         OpenPVSignal:Reports_group ;
                                OpenPVSignal:is_subgroup_of :reportsWithRecoveryAsOutcome ;
                                OpenPVSignal:has_count 3 ;
                                OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                OpenPVSignal:refers_to_dechallenge_outcome "positive - condition not applied" ;
                                rdfs:label "reports with positive dechallenge" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#reportsWithPositiveRechallenge
:reportsWithPositiveRechallenge rdf:type owl:NamedIndividual ,
                                         OpenPVSignal:Reports_group ;
                                OpenPVSignal:is_subgroup_of :reportsAfterEliminationOfDuplicates ;
                                OpenPVSignal:has_count 2 ;
                                OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                OpenPVSignal:refers_to_rechallenge_outcome "positive rechallenge - condition appeared again" ;
                                rdfs:label "reports with positive rechallenge " .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#reportsWithRecoveryAsOutcome
:reportsWithRecoveryAsOutcome rdf:type owl:NamedIndividual ,
                                       OpenPVSignal:Reports_group ;
                              OpenPVSignal:is_subgroup_of :reportsAfterEliminationOfDuplicates ;
                              OpenPVSignal:has_count 12 ;
                              OpenPVSignal:refers_to_database "WHO Vigibase" ;
                              OpenPVSignal:refers_to_outcome_after_action "recovery with no further information" ;
                              rdfs:label "reports with recovery as outcome " .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#reportsWithTimeToOnset
:reportsWithTimeToOnset rdf:type owl:NamedIndividual ,
                                 OpenPVSignal:Reports_group ;
                        OpenPVSignal:is_subgroup_of :reportsAfterEliminationOfDuplicates ;
                        OpenPVSignal:time_to_onset :time_to_onset_info ;
                        OpenPVSignal:has_count 14 ;
                        OpenPVSignal:refers_to_database "WHO Vigibase" ;
                        rdfs:label "reports with time to onset" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#reportsWithVemurafenibAndARF
:reportsWithVemurafenibAndARF rdf:type owl:NamedIndividual ,
                                       OpenPVSignal:Reports_group ;
                              OpenPVSignal:refers_to_adverse_effect :renalFailureAcute ;
                              OpenPVSignal:refers_to_drug :vemurafenib ;
                              OpenPVSignal:has_count 25 ;
                              OpenPVSignal:refers_to_database "WHO Vigibase" ;
                              rdfs:label "reports with vemurafenib and ARF" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#reportsWithVemurafenibAndCRF
:reportsWithVemurafenibAndCRF rdf:type owl:NamedIndividual ,
                                       OpenPVSignal:Reports_group ;
                              OpenPVSignal:refers_to_adverse_effect :renalFailureChronic ;
                              OpenPVSignal:refers_to_drug :vemurafenib ;
                              OpenPVSignal:has_count 16 ;
                              OpenPVSignal:refers_to_database "WHO Vigibase" ;
                              rdfs:label "reports with vemurafenib and CRF" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#reportsWithVemurafenibAndRenalFailureAggrevated
:reportsWithVemurafenibAndRenalFailureAggrevated rdf:type owl:NamedIndividual ,
                                                          OpenPVSignal:Reports_group ;
                                                 OpenPVSignal:is_subgroup_of :reportsAfterEliminationOfDuplicates ;
                                                 OpenPVSignal:refers_to_adverse_effect :renalFailureAcute ,
                                                                                       :renalFailureAggravated ,
                                                                                       :renalFailureChronic ;
                                                 OpenPVSignal:has_count 1 ;
                                                 OpenPVSignal:refers_to_database "WHO Vigibase" ;
                                                 rdfs:label "reports with vemurafenib and renal failure aggrevated" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#reportsWithWithdrawal
:reportsWithWithdrawal rdf:type owl:NamedIndividual ,
                                OpenPVSignal:Reports_group ;
                       OpenPVSignal:is_subgroup_of :reportsWithNoRecovery ;
                       OpenPVSignal:has_count 3 ;
                       OpenPVSignal:refers_to_database "WHO Vigibase" ;
                       OpenPVSignal:refers_to_dechallenge_outcome "negative - condition still applied" ;
                       rdfs:label "reports with withdrawal" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#respiratoryArrest
:respiratoryArrest rdf:type owl:NamedIndividual ,
                            OpenPVSignal:Adverse_Effect ;
                   OpenPVSignal:has_ICD_code "R092" ;
                   OpenPVSignal:has_MedDRA_code 10038669 ;
                   OpenPVSignal:has_MedDRA_prefered_term "Respiratory arrest" ;
                   rdfs:label "respiratory arrest" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#rosuvastatin
:rosuvastatin rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Drug ;
              OpenPVSignal:has_ATC_code "C10AA07" ,
                                        "C10BA06" ,
                                        "C10BX05" ,
                                        "C10BX07" ,
                                        "C10BX09" ,
                                        "C10BX10" ,
                                        "G01AE10" ;
              rdfs:label "rosuvastatin" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#sennaGlycosides
:sennaGlycosides rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Drug ;
                 OpenPVSignal:has_ATC_code "A06AB06" ;
                 rdfs:label "senna glycosides" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#sepsis
:sepsis rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Adverse_Effect ;
        OpenPVSignal:has_ICD_code "A41" ;
        OpenPVSignal:has_MedDRA_code 10040047 ;
        OpenPVSignal:has_MedDRA_prefered_term "Sepsis" ;
        rdfs:label "sepsis" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#sertraline
:sertraline rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "N06AB06" ;
            rdfs:label "sertraline" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#simvastatin
:simvastatin rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "A10BH51" ,
                                       "C10AA01" ,
                                       "C10BA02" ,
                                       "C10BA04" ,
                                       "C10BX01" ,
                                       "C10BX04" ;
             rdfs:label "simvastatin" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#sitagliptin
:sitagliptin rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_ATC_code "A10BD07" ,
                                       "A10BD12" ,
                                       "A10BH01" ,
                                       "A10BH51" ;
             rdfs:label "sitagliptin" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#sloughingOfSkin
:sloughingOfSkin rdf:type owl:NamedIndividual ,
                          OpenPVSignal:Adverse_Effect ;
                 OpenPVSignal:has_ICD_code "L491" ;
                 OpenPVSignal:has_MedDRA_code 10041041 ;
                 OpenPVSignal:has_MedDRA_prefered_term "Sloughing of skin" ;
                 rdfs:label "sloughing of skin" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#sodiumPolystyreneSulfonate
:sodiumPolystyreneSulfonate rdf:type owl:NamedIndividual ,
                                     OpenPVSignal:Drug ;
                            OpenPVSignal:has_ATC_code "V03AE05" ;
                            rdfs:label "sodium polystyrene sulfonate" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#sorafenib
:sorafenib rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "L01EX02" ;
           rdfs:label "sorafenib" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#spironolactone
:spironolactone rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Drug ;
                OpenPVSignal:has_ATC_code "C03DA01" ;
                rdfs:label "spironolactone" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#sunburn
:sunburn rdf:type owl:NamedIndividual ,
                  OpenPVSignal:Adverse_Effect ;
         OpenPVSignal:has_ICD_code "L550" ;
         OpenPVSignal:has_MedDRA_code 10042496 ;
         OpenPVSignal:has_MedDRA_prefered_term "Sunburn" ;
         rdfs:label "sunburn" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#sunitinib
:sunitinib rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "L01EX01" ;
           rdfs:label "sunitinib" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#systemicInflammatoryResponseSyndrome
:systemicInflammatoryResponseSyndrome rdf:type owl:NamedIndividual ,
                                               OpenPVSignal:Adverse_Effect ;
                                      OpenPVSignal:has_ICD_code "R6511" ;
                                      OpenPVSignal:has_MedDRA_code 10051379 ;
                                      OpenPVSignal:has_MedDRA_prefered_term "Systemic inflammatory response syndrome" ;
                                      rdfs:label "systemic inflammatory response syndrome" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#tamsulosin
:tamsulosin rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "G04CA02" ,
                                      "G04CA52" ,
                                      "G04CA53" ;
            rdfs:label "tamsulosin" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#temazepam
:temazepam rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "N05CD07" ;
           rdfs:label "temazepam" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#temozolomide
:temozolomide rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Drug ;
              OpenPVSignal:has_ATC_code "L01AX03" ;
              rdfs:label "temozolomide" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#time_to_onset_info
:time_to_onset_info rdf:type owl:NamedIndividual ,
                             time:DurationDescription ;
                    OpenPVSignal:has_content "Time to onset was reported in 14 of the 38 ICSRs. It ranged from three days to six months." ,
                                             "Time to onset was reported in 14 of the reports and ranged from two days to six months. The six reports with a time to onset within a month are suggestive of a drug-induced effect." ;
                    rdfs:label "time to onset info" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#timolol
:timolol rdf:type owl:NamedIndividual ,
                  OpenPVSignal:Drug ;
         OpenPVSignal:has_ATC_code "C07AA06" ,
                                   "C07BA06" ,
                                   "C07DA06" ,
                                   "S01ED01" ,
                                   "S01ED51" ;
         rdfs:label "timolol" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#tremor
:tremor rdf:type owl:NamedIndividual ,
                 OpenPVSignal:Adverse_Effect ;
        OpenPVSignal:has_ICD_code "R251" ;
        OpenPVSignal:has_MedDRA_code 10044565 ;
        OpenPVSignal:has_MedDRA_prefered_term "Tremor" ;
        rdfs:label "tremor" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#ureaBloodIncreased
:ureaBloodIncreased rdf:type owl:NamedIndividual ,
                             OpenPVSignal:Adverse_Effect ;
                    OpenPVSignal:has_ICD_code "R7989" ;
                    OpenPVSignal:has_MedDRA_code 10005851 ;
                    OpenPVSignal:has_MedDRA_prefered_term "Blood urea increased" ;
                    rdfs:label "urea blood increased" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#uricAcidBloodIncreased
:uricAcidBloodIncreased rdf:type owl:NamedIndividual ,
                                 OpenPVSignal:Adverse_Effect ;
                        OpenPVSignal:has_ICD_code "E79.0" ;
                        OpenPVSignal:has_MedDRA_code 10005861 ;
                        OpenPVSignal:has_MedDRA_prefered_term "Blood uric acid increased" ;
                        rdfs:label "uric acid blood increased" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#urinaryTractInfection
:urinaryTractInfection rdf:type owl:NamedIndividual ,
                                OpenPVSignal:Adverse_Effect ;
                       OpenPVSignal:has_ICD_code "N390 " ;
                       OpenPVSignal:has_MedDRA_code 10046571 ;
                       OpenPVSignal:has_MedDRA_prefered_term "Urinary tract infection" ;
                       rdfs:label "urinary tract infection" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#usage_of_vemurafenib
:usage_of_vemurafenib rdf:type owl:NamedIndividual ,
                               OpenPVSignal:Drug_Usage ;
                      OpenPVSignal:concerns_indication_for_use :BRAF_V600_mutation_positive ,
                                                               :MetastaticMalignantMelanoma ;
                      OpenPVSignal:is_related_with_drug_intake :oral_administration ;
                      OpenPVSignal:refers_to_drug :vemurafenib ;
                      rdfs:label "usage of vemurafenib" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#valaciclovir
:valaciclovir rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Drug ;
              OpenPVSignal:has_ATC_code "J05AB11" ,
                                        "R03DA20" ;
              rdfs:label "valaciclovir" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#valproicAcid
:valproicAcid rdf:type owl:NamedIndividual ,
                       OpenPVSignal:Drug ;
              OpenPVSignal:has_ATC_code "N03AG01" ;
              rdfs:label "valproic acid" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#vardenafil
:vardenafil rdf:type owl:NamedIndividual ,
                     OpenPVSignal:Drug ;
            OpenPVSignal:has_ATC_code "G04BE09" ;
            rdfs:label "vardenafil" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#vemurafenib
:vemurafenib rdf:type owl:NamedIndividual ,
                      OpenPVSignal:Drug ;
             OpenPVSignal:has_mechanism :MechanismContent ;
             OpenPVSignal:has_ATC_code "L01EC01" ;
             rdfs:label "vemurafenib" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#ventricularDysfunction
:ventricularDysfunction rdf:type owl:NamedIndividual ,
                                 OpenPVSignal:Adverse_Effect ;
                        OpenPVSignal:has_ICD_code "I50.1" ;
                        OpenPVSignal:has_MedDRA_code 10059056 ;
                        OpenPVSignal:has_MedDRA_prefered_term "Ventricular dysfunction" ;
                        rdfs:label "ventricular dysfunction" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#vomiting
:vomiting rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Adverse_Effect ;
          OpenPVSignal:has_ICD_code "R11" ,
                                    "R1110" ;
          OpenPVSignal:has_MedDRA_code 10047700 ;
          OpenPVSignal:has_MedDRA_prefered_term "Vomiting" ;
          rdfs:label "vomiting" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#warfarin
:warfarin rdf:type owl:NamedIndividual ,
                   OpenPVSignal:Drug ;
          OpenPVSignal:has_ATC_code "B01AA03" ;
          rdfs:label "warfarin" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#weightDecrease
:weightDecrease rdf:type owl:NamedIndividual ,
                         OpenPVSignal:Adverse_Effect ;
                OpenPVSignal:has_ICD_code "R634" ;
                OpenPVSignal:has_MedDRA_code 10047895 ;
                OpenPVSignal:has_MedDRA_prefered_term "Weight decreased" ;
                rdfs:label "weight decrease" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#zopiclone
:zopiclone rdf:type owl:NamedIndividual ,
                    OpenPVSignal:Drug ;
           OpenPVSignal:has_ATC_code "N05CF01" ;
           rdfs:label "zopiclone" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#amoxicillin_sodium/_clavulanate_potassium
<http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#amoxicillin_sodium/_clavulanate_potassium> rdf:type owl:NamedIndividual ,
                                                                                                                           OpenPVSignal:Drug ;
                                                                                                                  OpenPVSignal:has_ATC_code "J01CR02" ;
                                                                                                                  rdfs:label "amoxicillin sodium/ clavulanate potassium" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#chlortalidone/atenolol
<http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#chlortalidone/atenolol> rdf:type owl:NamedIndividual ,
                                                                                                        OpenPVSignal:Drug ;
                                                                                               OpenPVSignal:has_ATC_code "C07CB03" ;
                                                                                               rdfs:label "chlortalidone/atenolol" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#citricacid/potassiumbicarbonate/PotassiumCitrate
<http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#citricacid/potassiumbicarbonate/PotassiumCitrate> rdf:type owl:NamedIndividual ,
                                                                                                                                  OpenPVSignal:Drug ;
                                                                                                                         OpenPVSignal:has_ATC_code "G04B" ;
                                                                                                                         rdfs:label "citric acid/potassium bicarbonate/ potassium citrate" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#menthol/zincOxide
<http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#menthol/zincOxide> rdf:type owl:NamedIndividual ,
                                                                                                   OpenPVSignal:Drug ;
                                                                                          OpenPVSignal:has_ATC_code "C05AX04" ;
                                                                                          rdfs:label "menthol/zinc oxide" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#paracetamol_/_hydrocodone
<http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#paracetamol_/_hydrocodone> rdf:type owl:NamedIndividual ,
                                                                                                           OpenPVSignal:Drug ;
                                                                                                  OpenPVSignal:has_ATC_code "N02BE01" ,
                                                                                                                            "R05DA03" ;
                                                                                                  rdfs:label "paracetamol / hydrocodone" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#piperacillin/tazobactam
<http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#piperacillin/tazobactam> rdf:type owl:NamedIndividual ,
                                                                                                         OpenPVSignal:Drug ;
                                                                                                OpenPVSignal:has_ATC_code "J01CR05" ;
                                                                                                rdfs:label "piperacillin/tazobactam" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#sodiumbicarbonate/potassium
<http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#sodiumbicarbonate/potassium> rdf:type owl:NamedIndividual ,
                                                                                                             OpenPVSignal:Drug ;
                                                                                                    OpenPVSignal:has_ATC_code "A02AH" ;
                                                                                                    rdfs:label "sodium bicarbonate/potassium" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#sodiumbicarbonate/potassiumchloride/sodiumchloride/macrogol
<http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#sodiumbicarbonate/potassiumchloride/sodiumchloride/macrogol> rdf:type owl:NamedIndividual ,
                                                                                                                                             OpenPVSignal:Drug ;
                                                                                                                                    OpenPVSignal:has_ATC_code "A06AD65" ;
                                                                                                                                    rdfs:label "sodium bicarbonate/potassium chloride/sodium chloride/macrogol" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#valsartan/amlodipine
<http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#valsartan/amlodipine> rdf:type owl:NamedIndividual ,
                                                                                                      OpenPVSignal:Drug ;
                                                                                             OpenPVSignal:has_ATC_code "C08CA01" ;
                                                                                             rdfs:label "valsartan/amlodipine" .


###  http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#vitamins/minerals
<http://purl.org/OpenPVSignal/Signals/2014_3_Vemurafenib_renal_failure#vitamins/minerals> rdf:type owl:NamedIndividual ,
                                                                                                   OpenPVSignal:Drug ;
                                                                                          OpenPVSignal:has_ATC_code "A11AA" ;
                                                                                          rdfs:label "vitamins/minerals" .


###  Generated by the OWL API (version 4.5.9.2019-02-01T07:24:44Z) https://github.com/owlcs/owlapi
